[{"title01":"Leucocytosis during induction therapy with all-trans-retinoic acid and arsenic trioxide in acute promyelocytic leukaemia predicts differentiation syndrome and treatment-related complications","title02":"Leucocytosis during induction therapy with all-trans<\/i>-retinoic acid and arsenic trioxide in acute promyelocytic leukaemia predicts differentiation syndrome and treatment-related complications","journal":"Br J Haematol","issue":"2024 Sep 14. doi: 10.1111\/bjh.19759. Online ahead of print.","author":"Cicconi L, Bisegna M, Gurnari C, Fanciullo D, Piciocchi A, Marsili G, Minotti C, Scalzulli E, Mandelli B, Guarnera L, Perrone S, Ortu La Barbera E, Mecarocci S, Biagi A, Cenfra N, Corbingi A, Scerpa MC, Venditti A, Martelli M, Voso MT, Breccia M, Pulsoni A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39275865"},{"title01":"Comment to “Sequencing of cellular therapy and bispecific antibodies for the management of diffuse large B-cell lymphoma”: chimeric antigen receptor T-cell therapy remains effective after exposure to bispecific antibodies","title02":"Comment to “Sequencing of cellular therapy and bispecific antibodies for the management of diffuse large B-cell lymphoma”: chimeric antigen receptor T-cell therapy remains effective after exposure to bispecific antibodies","journal":"Haematologica","issue":"2024 Sep 19. doi: 10.3324\/haematol.2024.286353. Online ahead of print.","author":"Crochet G, Houot R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39295315"},{"title01":"ERK1\/2 pro-survival signalling is suppressed by pirtobrutinib in ibrutinib-resistant MYD88-mutated lymphoma cells","title02":"ERK1\/2 pro-survival signalling is suppressed by pirtobrutinib in ibrutinib-resistant MYD88<\/i>-mutated lymphoma cells","journal":"Br J Haematol","issue":"2024 Sep 18. doi: 10.1111\/bjh.19756. Online ahead of print.","author":"Munshi M, Liu X, Kofides A, Tsakmaklis N, Hunter ZR, Guerrera ML, Canning A, Gustine JN, Liu S, Hatcher JM, Chen J, Meid K, Sarosiek S, Flynn CA, Branagan AR, von Keudell G, Palomba LM, Castillo JJ, Yang G, Treon SP.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39295138"},{"title01":"The current landscape of frontline large B-cell lymphoma trials","title02":"The current landscape of frontline large B-cell lymphoma trials","journal":"Blood","issue":"2024 Sep 24:blood.2023023789. doi: 10.1182\/blood.2023023789. Online ahead of print.","author":"Qualls DA, Armand P, Salles GA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39316716"},{"title01":"LocoMMotion: a study of real-life current standards of care in triple-class exposed patients with relapsed\/refractory multiple myeloma – 2-year follow-up (final analysis)","title02":"LocoMMotion: a study of real-life current standards of care in triple-class exposed patients with relapsed\/refractory multiple myeloma – 2-year follow-up (final analysis)","journal":"Leukemia","issue":"2024 Sep 25. doi: 10.1038\/s41375-024-02404-6. Online ahead of print.","author":"Mateos MV, Weisel K, De Stefano V, Goldschmidt H, Delforge M, Mohty M, Dytfeld D, Angelucci E, Vincent L, Perrot A, Benjamin R, van de Donk NWCJ, Ocio EM, Roccia T, Schecter JM, Koskinen S, Haddad I, Strulev V, Mitchell L, Buyze J, Filho OC, Einsele H, Moreau P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39322709"},{"title01":"PVR (CD155) epigenetic status mediates immunotherapy response in multiple myeloma","title02":"PVR (CD155) epigenetic status mediates immunotherapy response in multiple myeloma","journal":"Leukemia","issue":"2024 Sep 24. doi: 10.1038\/s41375-024-02419-z. Online ahead of print.","author":"Martinez-Verbo L, Veselinova Y, Llin\u00e0s-Arias P, Garc\u00eda-Prieto CA, Noguera-Castells A, Pato ML, Bueno-Costa A, Campillo-Marcos I, Villanueva L, Oliver-Caldes A, Cardus O, Salsench SV, Garc\u00eda-Ortiz A, Valeri A, Rojas EA, Barrena N, Guti\u00e9rrez NC, Pr\u00f3sper F, Agirre X, Fern\u00e1ndez de Larrea C, Mart\u00ednez-L\u00f3pez J, Ferrer G, Esteller M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39322713"},{"title01":"A phase I study of MAGE-A1-targeted T1367 T-cell receptor-based cell therapy in patients with advanced multiple myeloma","title02":"A phase I study of MAGE-A1-targeted T1367 T-cell receptor-based cell therapy in patients with advanced multiple myeloma","journal":"Haematologica","issue":"2024 Sep 12. doi: 10.3324\/haematol.2024.286124. Online ahead of print.","author":"Kr\u00fcger J, Obenaus M, Blau IW, Hoser D, Vaegler M, Rauschenbach H, Anagnostopoulos I, J\u00f6hrens K, Scheuplein V, Kieback E, B\u00f6hme J, Von Br\u00fcnneck AC, Kr\u00f6nke J, Busse A, Willimsky G, Blankenstein T, Pezzutto A, Keller U, Nogai A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39279443"},{"title01":"Novel finding of vaccine-derived rubella virus-associated granulomata in an adult patient post-allogeneic haematopoietic stem cell transplant","title02":"Novel finding of vaccine-derived rubella virus-associated granulomata in an adult patient post-allogeneic haematopoietic stem cell transplant","journal":"Br J Haematol","issue":"2024 Sep 15. doi: 10.1111\/bjh.19762. Online ahead of print.","author":"Durity E, Zheng J, Sanchez E, Donati M, Perry K, Derrick J, Taylor A, Fink C, Holden J, Grant P, Byott M, Rickaby W, Asher N, Walker SL, Thomson K, Bunker C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39279194"},{"title01":"Impaired microvascular function in patients with sickle cell anemia and leg ulcers improved with healing","title02":"Impaired microvascular function in patients with sickle cell anemia and leg ulcers improved with healing","journal":"Br J Haematol","issue":"2024 Sep 24. doi: 10.1111\/bjh.19785. Online ahead of print.","author":"Catella J, Turpin E, Connes P, Nader E, Carin R, Martin M, Rezigue H, Nougier C, Dargaud Y, Josset-Lamaugarny A, Dugrain J, Marano M, Leuci A, Boisson C, Renoux C, Joly P, Poutrel S, Hot A, Guillot N, Fromy B.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39318045"},{"title01":"Fanconi anemia: realizing hematopoietic cure","title02":"Fanconi anemia: realizing hematopoietic cure","journal":"Blood","issue":"2024 Sep 19;144(12):1245-1246.","author":"Satty AM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39298158"},{"title01":"Transplant outcome in pediatric Fanconi anemia","title02":"Transplant outcome in pediatric Fanconi anemia","journal":"Blood","issue":"2024 Sep 19;144(12):1350.","author":"No authors listed","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39298164"},{"title01":"Efficacy and safety of recombinant human thrombopoietin for the treatment of chronic primary immune thrombocytopenia in children and adolescents: A multicentre, randomized, double-blind, placebo-controlled phase III trial","title02":"Efficacy and safety of recombinant human thrombopoietin for the treatment of chronic primary immune thrombocytopenia in children and adolescents: A multicentre, randomized, double-blind, placebo-controlled phase III trial","journal":"Br J Haematol","issue":"2024 Sep 12. doi: 10.1111\/bjh.19761. Online ahead of print.","author":"Ma J, Zhang X, Zhao L, Wu X, Yao Y, Liu W, Wang X, Ju X, Shi X, Sun L, Zheng L, Liu S, Qian J, Wu R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39267281"},{"title01":"Longitudinal follow up of a phase 2 trial of venetoclax added to hyper-CVAD, nelarabine and pegylated asparaginase in patients with T-cell acute lymphoblastic leukemia and lymphoma","title02":"Longitudinal follow up of a phase 2 trial of venetoclax added to hyper-CVAD, nelarabine and pegylated asparaginase in patients with T-cell acute lymphoblastic leukemia and lymphoma","journal":"Leukemia","issue":"2024 Sep 25. doi: 10.1038\/s41375-024-02414-4. Online ahead of print.","author":"Ravandi F, Senapati J, Jain N, Short NJ, Kadia T, Borthakur G, Konopleva M, Wierda W, Huang X, Maiti A, Issa G, Balkin H, Garris R, Ferrajoli A, Garcia-Manero G, Alvarado Y, Kebriaei P, Jabbour E, Kantarjian HM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39322712"},{"title01":"Eltrombopag in chronic myelomonocytic leukemia with severe thrombocytopenia. A Groupe Francophone des My\u00e9lodysplasies (GFM) study","title02":"Eltrombopag in chronic myelomonocytic leukemia with severe thrombocytopenia. A Groupe Francophone des My\u00e9lodysplasies (GFM) study","journal":"Leukemia","issue":"2024 Sep 12. doi: 10.1038\/s41375-024-02402-8. Online ahead of print.","author":"Rabian F, Chevret S, Gruson B, Th\u00e9pot S, Walter-Petrich A, Braun T, Vey N, Torregrosa-Diaz JM, Peterlin P, Toma A, D'Aveni M, Delaunay J, Legros L, Droin N, Chermat F, Lusina D, Ad\u00e8s L, Sapena R, Solary E, Fenaux P, Itzykson R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39266637"},{"title01":"USP4 regulates ribosome biogenesis and protein synthesis for hematopoietic stem cell regeneration and leukemia progression","title02":"USP4 regulates ribosome biogenesis and protein synthesis for hematopoietic stem cell regeneration and leukemia progression","journal":"Leukemia","issue":"2024 Sep 12. doi: 10.1038\/s41375-024-02338-z. Online ahead of print.","author":"Liu B, Zhang X, Zhou Y, Liu H, Wang Z, Fu Y, Gao Q, Cheng X, Sun Q, Ju Z.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39266638"},{"title01":"HDAC7 is a potential therapeutic target in acute erythroid leukemia","title02":"HDAC7 is a potential therapeutic target in acute erythroid leukemia","journal":"Leukemia","issue":"2024 Sep 15. doi: 10.1038\/s41375-024-02394-5. Online ahead of print.","author":"Zhang W, Yamamoto K, Chang YH, Yabushita T, Hao Y, Shimura R, Nakahara J, Shikata S, Iida K, Chen Q, Zhang X, Kitamura T, Goyama S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39277669"},{"title01":"Efficient combinatorial adaptor-mediated targeting of acute myeloid leukemia with CAR T-cells","title02":"Efficient combinatorial adaptor-mediated targeting of acute myeloid leukemia with CAR T-cells","journal":"Leukemia","issue":"2024 Sep 18. doi: 10.1038\/s41375-024-02409-1. Online ahead of print.","author":"Volta L, Myburgh R, Pellegrino C, Koch C, Maurer M, Manfredi F, Hofstetter M, Kaiser A, Schneiter F, M\u00fcller J, Buehler MM, De Luca R, Favalli N, Magnani CF, Schroeder T, Neri D, Manz MG.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39294295"},{"title01":"Triplet therapy for advanced BCR::ABL1 positive myeloid leukaemias","title02":"Triplet therapy for advanced BCR::ABL1 positive myeloid leukaemias","journal":"Lancet Haematol","issue":"2024 Sep 17:S2352-3026(24)00282-5. doi: 10.1016\/S2352-3026(24)00282-5. Online ahead of print.","author":"Copland M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39303728"},{"title01":"Decitabine, venetoclax, and ponatinib for advanced phase chronic myeloid leukaemia and Philadelphia chromosome-positive acute myeloid leukaemia: a single-arm, single-centre phase 2 trial","title02":"Decitabine, venetoclax, and ponatinib for advanced phase chronic myeloid leukaemia and Philadelphia chromosome-positive acute myeloid leukaemia: a single-arm, single-centre phase 2 trial","journal":"Lancet Haematol","issue":"2024 Sep 17:S2352-3026(24)00250-3. doi: 10.1016\/S2352-3026(24)00250-3. Online ahead of print.","author":"Short NJ, Nguyen D, Jabbour E, Senapati J, Zeng Z, Issa GC, Abbas H, Nasnas C, Qiao W, Huang X, Borthakur G, Chien K, Haddad FG, Pemmaraju N, Karrar OS, Nguyen D, Konopleva M, Kantarjian H, Ravandi F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39303729"},{"title01":"Transplantation and long-term overall survival in acute myeloid leukaemia","title02":"Transplantation and long-term overall survival in acute myeloid leukaemia","journal":"Lancet Haematol","issue":"2024 Sep 20:S2352-3026(24)00274-6. doi: 10.1016\/S2352-3026(24)00274-6. Online ahead of print.","author":"Perusini MA, Yee KWL.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39312919"},{"title01":"Venetoclax plus decitabine as a bridge to allogeneic haematopoietic stem-cell transplantation in older patients with acute myeloid leukaemia (VEN-DEC GITMO): final report of a multicentre, single-arm, phase 2 trial","title02":"Venetoclax plus decitabine as a bridge to allogeneic haematopoietic stem-cell transplantation in older patients with acute myeloid leukaemia (VEN-DEC GITMO): final report of a multicentre, single-arm, phase 2 trial","journal":"Lancet Haematol","issue":"2024 Sep 20:S2352-3026(24)00241-2. doi: 10.1016\/S2352-3026(24)00241-2. Online ahead of print.","author":"Russo D, Polverelli N, Bernardi S, Santarone S, Farina M, Borlenghi E, Onida F, Castagna L, Bramanti S, Carella AM, Sorasio R, Martino M, Alati C, Olivieri A, Beltrami G, Curti A, Vetro C, Leotta S, Mancini V, Terruzzi E, Bernardi M, Galieni P, Musto P, Cerretti R, Giaccone L, Skert C, Radici V, Vezzoli M, Calza S, Leoni A, Garuffo L, Bonvicini C, Pellizzeri S, Malagola M, Ciceri F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39312920"},{"title01":"Randomized Phase III SIERRA Trial of (131)I-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed\/Refractory AML","title02":"Randomized Phase III SIERRA Trial of (131)I-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed\/Refractory AML","journal":"J Clin Oncol","issue":"2024 Sep 19:JCO2302018. doi: 10.1200\/JCO.23.02018. Online ahead of print.","author":"Gyurkocza B, Nath R, Seropian S, Choe H, Litzow MR, Abboud C, Koshy N, Stiff P, Tomlinson B, Abhyankar S, Foran J, Hari P, Chen G, Al-Kadhimi Z, Kebriaei P, Sabloff M, Orozco JJ, Jamieson K, Silverman M, Van Besien K, Schuster M, Law AD, Larkin K, Pandit-Taskar N, Rowley SD, Munshi P, Cook R, Levy MY, Lazarus HM, Sandmaier BM, Pagel JM, Reddy V, MacDougall J, McNamara K, Spross J, Haeuber E, Vusirikala M, Nahar A, Desai A, Giralt S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39298738"},{"title01":"Single or Double Induction With 7 + 3 Containing Standard or High-Dose Daunorubicin for Newly Diagnosed AML: The Randomized DaunoDouble Trial by the Study Alliance Leukemia","title02":"Single or Double Induction With 7 + 3 Containing Standard or High-Dose Daunorubicin for Newly Diagnosed AML: The Randomized DaunoDouble Trial by the Study Alliance Leukemia","journal":"J Clin Oncol","issue":"2024 Sep 16:JCO2400235. doi: 10.1200\/JCO.24.00235. Online ahead of print.","author":"R\u00f6llig C, Steffen B, Schliemann C, Mikesch JH, Alakel N, Herbst R, H\u00e4nel M, Noppeney R, Hanoun M, Kaufmann M, Weinbergerova B, Sch\u00e4fer-Eckart K, Sauer T, Neubauer A, Burchert A, Baldus CD, Mertov\u00e1 J, Jost E, Niemann D, Nov\u00e1k J, Krause SW, Scholl S, Hochhaus A, Held G, Szotkowski T, Rank A, Schmid C, Fransecky L, Kayser S, Schaich M, Kramer M, Fiebig F, Haake A, Schetelig J, Middeke JM, St\u00f6lzel F, Platzbecker U, Thiede C, M\u00fcller-Tidow C, Berdel WE, Ehninger G, Mayer J, Serve H, Bornh\u00e4user M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39284116"},{"title01":"Philadelphia-like B-cell acute lymphoblastic Leukaemia: Disease features and outcomes in the era of immunotherapy","title02":"Philadelphia-like B-cell acute lymphoblastic Leukaemia: Disease features and outcomes in the era of immunotherapy","journal":"Br J Haematol","issue":"2024 Sep 18. doi: 10.1111\/bjh.19771. Online ahead of print.","author":"Ashouri K, Hom B, Ginosyan AA, Rahimi Y, Resnick K, Nittur V, Hwang J, Ireland R, Ann B, Adnani B, Bragasin EI, Chaudhary P, Ali A, Woan K, Tam EL, Siddiqi I, Ladha A, Yaghmour G.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39295195"},{"title01":"Oral decitabine\/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study","title02":"Oral decitabine\/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study","journal":"Br J Haematol","issue":"2024 Sep 23. doi: 10.1111\/bjh.19741. Online ahead of print.","author":"Geissler K, Koristek Z, Del Castillo TB, Nov\u00e1k J, Rodr\u00edguez-Mac\u00edas G, Metzelder SK, Illes A, Mayer J, Arnan M, Keating MM, Krauter J, Lunghi M, Fracchiolla NS, Platzbecker U, Santini V, Sano Y, Oganesian A, Keer H, L\u00fcbbert M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39313917"},{"title01":"Impact of the COVID-19 pandemic on treatment of patients with acute myeloid leukaemia in India","title02":"Impact of the COVID-19 pandemic on treatment of patients with acute myeloid leukaemia in India","journal":"Br J Haematol","issue":"2024 Sep 16. doi: 10.1111\/bjh.19750. Online ahead of print.","author":"Philip C, Selvarajan S, Nayak L, Jain H, Kulkarni U, Samuel P, Agrawal N, Kayal S, Mishra K, Pavitra DS, Jayachandran PK, Bala SC, Raghavan V, Paul M, Singh J, Sreeraj V, Mujumdar S, Nayak A, Prakash O, Barath U, Dharmaraj A, Rajendra A, Thorat J, Bagal B, Abraham A, Bhurani D, Ganesan P, Sengar M, Mathews V.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39279532"},{"title01":"A critical review of management of allogeneic transplant-eligible adults with Ph+ acute lymphoblastic leukaemia","title02":"A critical review of management of allogeneic transplant-eligible adults with Ph+ acute lymphoblastic leukaemia","journal":"Br J Haematol","issue":"2024 Sep 17. doi: 10.1111\/bjh.19682. Online ahead of print.","author":"Shanmuganathan N, Grigg A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39289867"},{"title01":"SHERLOCK unmasks fusion-driven leukemias","title02":"SHERLOCK unmasks fusion-driven leukemias","journal":"Blood","issue":"2024 Sep 19;144(12):1241-1243.","author":"Bonadies N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39298156"},{"title01":"Pretransplant MRD detection of fusion transcripts is strongly prognostic in KMT2A-rearranged acute myeloid leukemia","title02":"Pretransplant MRD detection of fusion transcripts is strongly prognostic in KMT2A-rearranged acute myeloid leukemia","journal":"Blood","issue":"2024 Sep 24:blood.2024026605. doi: 10.1182\/blood.2024026605. Online ahead of print.","author":"Loo S, Potter N, Ivey A, O'Nions J Dr, Moon R, Jovanovic J, Fong CY, Anstee NS, Tiong IS, Othman J, Chua CC, Renshaw H, Baker R, Fleming S, Russell NH, Ritchie D, Bajel A, Hou HA, Dillon RJ, Wei AH.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39316646"},{"title01":"Disruption of cotranscriptional splicing suggests that RBM39 is a therapeutic target in acute lymphoblastic leukemia","title02":"Disruption of cotranscriptional splicing suggests that RBM39 is a therapeutic target in acute lymphoblastic leukemia","journal":"Blood","issue":"2024 Sep 24:blood.2024024281. doi: 10.1182\/blood.2024024281. Online ahead of print.","author":"Jin Q, Harris E, Myers JA, Mehmood R, Cotton A, Shirnekhi HK, Baggett DW, Wen JQ, Schild AB, Bhansali RS, Klein J, Narina S, Pieters T, Yoshimi A, Pruett-Miller SM, Kriwacki R, Abdel-Wahab O, Malinge S, Ntziachristos P, Obeng EA, Crispino JD.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39316649"},{"title01":"Sustained Benefit of Zanubrutinib vs Ibrutinib in Patients With R\/R CLL\/SLL: Final Comparative Analysis of ALPINE","title02":"Sustained Benefit of Zanubrutinib vs Ibrutinib in Patients With R\/R CLL\/SLL: Final Comparative Analysis of ALPINE","journal":"Blood","issue":"2024 Sep 24:blood.2024024667. doi: 10.1182\/blood.2024024667. Online ahead of print.","author":"Brown JR, Eichhorst B, Lamanna N, O'Brien SM MD, Tam CS, Qiu L, Jurczak W, Zhou K, \u0160imkovi\u010d M, Mayer J, Gillespie-Twardy A, Ferrajoli A, Ganly PS, Weinkove R, Grosicki S, Mital A, Robak T Prof, Osterborg A, Yimer HA, Wang MY, Salmi T, Wang L, Li J, Wu K, Cohen AC, Shadman M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39316666"},{"title01":"Focal deletions of a promoter tether activate the IRX3 oncogene in T-cell acute lymphoblastic leukemia","title02":"Focal deletions of a promoter tether activate the IRX3 oncogene in T-cell acute lymphoblastic leukemia","journal":"Blood","issue":"2024 Sep 24:blood.2024024300. doi: 10.1182\/blood.2024024300. Online ahead of print.","author":"Rahman S, Bloye G, Farah N, Demeulemeester J, Costa JR, O'Connor D, Pocock R, Rapoz-D'Silva T, Turna A, Wang L, Lee SW, Fielding AK, Roels J, Jaksik R, Dawidowska M, Van Vlierberghe P, Hadjur S, Hughes JR, Davies J, Gutierrez A, Kelliher M, Van Loo P, Dawson MA, Mansour MR.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39316719"},{"title01":"How I Treat patients with AML using azacitidine and venetoclax","title02":"How I Treat patients with AML using azacitidine and venetoclax","journal":"Blood","issue":"2024 Sep 24:blood.2024024009. doi: 10.1182\/blood.2024024009. Online ahead of print.","author":"Wei AH, Loo S, Daver NG.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39316723"},{"title01":"Therapy response in AML: a tale of two T cells","title02":"Therapy response in AML: a tale of two T cells","journal":"Blood","issue":"2024 Sep 12;144(11):1134-1136.","author":"Penter L, Wu CJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39264613"},{"title01":"Epcoritamab in relapsed\/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trial","title02":"Epcoritamab in relapsed\/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trial","journal":"Leukemia","issue":"2024 Sep 25. doi: 10.1038\/s41375-024-02410-8. Online ahead of print.","author":"Thieblemont C, Karimi YH, Ghesquieres H, Cheah CY, Clausen MR, Cunningham D, Jurczak W, Do YR, Gasiorowski R, Lewis DJ, Kim TM, van der Poel M, Poon ML, Feldman T, Linton KM, Sureda A, Hutchings M, Dinh MH, Kilavuz N, Soong D, Mark T, Sacchi M, Phillips T, Lugtenburg PJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39322711"},{"title01":"Longitudinal follow up of a phase 2 trial of venetoclax added to hyper-CVAD, nelarabine and pegylated asparaginase in patients with T-cell acute lymphoblastic leukemia and lymphoma","title02":"Longitudinal follow up of a phase 2 trial of venetoclax added to hyper-CVAD, nelarabine and pegylated asparaginase in patients with T-cell acute lymphoblastic leukemia and lymphoma","journal":"Leukemia","issue":"2024 Sep 25. doi: 10.1038\/s41375-024-02414-4. Online ahead of print.","author":"Ravandi F, Senapati J, Jain N, Short NJ, Kadia T, Borthakur G, Konopleva M, Wierda W, Huang X, Maiti A, Issa G, Balkin H, Garris R, Ferrajoli A, Garcia-Manero G, Alvarado Y, Kebriaei P, Jabbour E, Kantarjian HM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39322712"},{"title01":"Pola-R-CHP or R-CHOEP for first-line therapy of younger patients with high-risk diffuse large B-cell lymphoma: a retrospective comparison of two randomized phase 3 trials","title02":"Pola-R-CHP or R-CHOEP for first-line therapy of younger patients with high-risk diffuse large B-cell lymphoma: a retrospective comparison of two randomized phase 3 trials","journal":"Leukemia","issue":"2024 Sep 25. doi: 10.1038\/s41375-024-02420-6. Online ahead of print.","author":"Lenz G, Tilly H, Ziepert M, Altmann B, Herbaux C, Frontzek F, Nickelsen M, Lee C, Hirata J, Sahin D, Chohan S, Batlevi CL, Yan M, Morschhauser F, Schmitz N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39322715"},{"title01":"Comprehensive genetic analysis by targeted sequencing identifies risk factors and predicts patient outcome in Mantle Cell Lymphoma: results from the EU-MCL network trials","title02":"Comprehensive genetic analysis by targeted sequencing identifies risk factors and predicts patient outcome in Mantle Cell Lymphoma: results from the EU-MCL network trials","journal":"Leukemia","issue":"2024 Sep 16. doi: 10.1038\/s41375-024-02375-8. Online ahead of print.","author":"Khouja M, Jiang L, Pal K, Stewart PJ, Regmi B, Schwarz M, Klapper W, Alig SK, Darzentas N, Kluin-Nelemans HC, Hermine O, Dreyling M, Gonzalez de Castro D, Hoster E, Pott C; European Mantle Cell Lymphoma Network.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39284897"},{"title01":"Potent combination benefit of the AKT inhibitor capivasertib and the BCL-2 inhibitor venetoclax in diffuse large B cell lymphoma","title02":"Potent combination benefit of the AKT inhibitor capivasertib and the BCL-2 inhibitor venetoclax in diffuse large B cell lymphoma","journal":"Leukemia","issue":"2024 Sep 16. doi: 10.1038\/s41375-024-02401-9. Online ahead of print.","author":"Willis BS, Mongeon K, Dry H, Neveras IL, Bryan N, Pandya M, Roderick-Richardson J, Xu W, Yang L, Rosen A, Reimer C, Tuskova L, Klener P, Mettetal JT, Lenz G, Barry ST.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39284898"},{"title01":"Atezolizumab, venetoclax, and obinutuzumab combination in Richter transformation diffuse large B-cell lymphoma (MOLTO): a multicentre, single-arm, phase 2 trial","title02":"Atezolizumab, venetoclax, and obinutuzumab combination in Richter transformation diffuse large B-cell lymphoma (MOLTO): a multicentre, single-arm, phase 2 trial","journal":"Lancet Oncol","issue":"2024 Sep 10:S1470-2045(24)00396-6. doi: 10.1016\/S1470-2045(24)00396-6. Online ahead of print.","author":"Tedeschi A, Frustaci AM, Condoluci A, Coscia M, Chiarle R, Zinzani PL, Motta M, Gaidano G, Quaresmini G, Scarf\u00f2 L, Catania G, Deodato M, Jones R, Tabanelli V, Griggio V, St\u00fcssi G, Calleri A, Pini K, Cairoli R, Zenz T, Signori A, Zucca E, Rossi D, Montillo M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39270702"},{"title01":"Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma)","title02":"Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma)","journal":"J Clin Oncol","issue":"2024 Sep 13:JCO2400554. doi: 10.1200\/JCO.24.00554. Online ahead of print.","author":"Tournilhac O, Altmann B, Friedrichs B, Bouabdallah K, Leclerc M, Cartron G, Turlure P, Reimer P, Wagner-Drouet E, Sanhes L, Houot R, Roussel M, Kroschinsky F, Dreger P, Viardot A, de Leval L, Rosenwald A, Gaulard P, Wulf G, Villate A, Latiere C, Elmaagacli A, Glass B, Poeschel V, Damaj G, Sibon D, Durot E, Bilger K, Banos A, Haenel M, Dreyling M, Keller U, Tiab M, Drenou B, Cornillon J, Nguyen S, Robin M, Nickelsen M, Tr\u00fcmper L, Lenz G, Ziepert M, Schmitz N; French Lymphoma Study Association (LYSA); Soci\u00e9t\u00e9 Francophone de greffe de moelle et Th\u00e9rapie Cellulaire (SFGM-TC); German Lymphoma Alliance (GLA); French Lymphoma Study Association (LYSA), Soci\u00e9t\u00e9 Francophone de greffe de moelle et Th\u00e9rapie Cellulaire (SFGM-TC), German Lymphoma Alliance (GLA).","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39270145"},{"title01":"Acalabrutinib alone or in combination with rituximab for follicular lymphoma: An open-label study","title02":"Acalabrutinib alone or in combination with rituximab for follicular lymphoma: An open-label study","journal":"Br J Haematol","issue":"2024 Sep 22. doi: 10.1111\/bjh.19787. Online ahead of print.","author":"Strati P, Champion R, Coleman M, Smith SM, Venugopal P, Martin P, Wood A, Miller K, Christian B.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39308028"},{"title01":"CNS prophylaxis in large B-cell lymphomas: A balance with three pans","title02":"CNS prophylaxis in large B-cell lymphomas: A balance with three pans","journal":"Br J Haematol","issue":"2024 Sep 14. doi: 10.1111\/bjh.19774. Online ahead of print.","author":"Calimeri T, Ferreri AJM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39275864"},{"title01":"A randomized trial of ibrutinib and R-GDP prior to stem cell transplant in relapsed diffuse large B-cell lymphoma","title02":"A randomized trial of ibrutinib and R-GDP prior to stem cell transplant in relapsed diffuse large B-cell lymphoma","journal":"Br J Haematol","issue":"2024 Sep 12. doi: 10.1111\/bjh.19764. Online ahead of print.","author":"Kuruvilla J, Rushton C, Villa D, Aslam M, Prica A, Abdel Samad N, Doucet S, Dudebout J, Fleury I, Fraser G, Larouche JF, Shafey M, Skrabek P, Skamene T, Morin RD, Alcaide M, Ben-Neriah S, Lee D, Winch C, Shepherd LE, Scott DW, Crump M, Chen BE, Hay AE.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39267295"},{"title01":"Sustained Benefit of Zanubrutinib vs Ibrutinib in Patients With R\/R CLL\/SLL: Final Comparative Analysis of ALPINE","title02":"Sustained Benefit of Zanubrutinib vs Ibrutinib in Patients With R\/R CLL\/SLL: Final Comparative Analysis of ALPINE","journal":"Blood","issue":"2024 Sep 24:blood.2024024667. doi: 10.1182\/blood.2024024667. Online ahead of print.","author":"Brown JR, Eichhorst B, Lamanna N, O'Brien SM MD, Tam CS, Qiu L, Jurczak W, Zhou K, \u0160imkovi\u010d M, Mayer J, Gillespie-Twardy A, Ferrajoli A, Ganly PS, Weinkove R, Grosicki S, Mital A, Robak T Prof, Osterborg A, Yimer HA, Wang MY, Salmi T, Wang L, Li J, Wu K, Cohen AC, Shadman M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39316666"},{"title01":"Intra-marrow delivery of human interleukin-6-loaded biodegradable microspheres promotes growth of patient-derived multiple myeloma cells in mice","title02":"Intra-marrow delivery of human interleukin-6-loaded biodegradable microspheres promotes growth of patient-derived multiple myeloma cells in mice","journal":"Haematologica","issue":"2024 Sep 12. doi: 10.3324\/haematol.2024.285980. Online ahead of print.","author":"Bariana M, Wang W, Yin Z, Sun J, Samimi S, Anuncio SA, Cassella E, Xu N, Hu W, Aptekmann A, Siegel DS, Chow KF, Wang H, Zakrzewski JL.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39279450"},{"title01":"A CD38\/CD3xCD28 trispecific T-cell engager as a potentially active agent in multiple myeloma patients relapsed and\/or refractory to anti-CD38 monoclonal antibodies","title02":"A CD38\/CD3xCD28 trispecific T-cell engager as a potentially active agent in multiple myeloma patients relapsed and\/or refractory to anti-CD38 monoclonal antibodies","journal":"Br J Haematol","issue":"2024 Sep 22. doi: 10.1111\/bjh.19784. Online ahead of print.","author":"Zabaleta A, Blanco L, Kim PS, Bisht K, Wang H, Van de Velde H, Lasa M, Tamariz-Amador LE, Rodriguez-Otero P, San-Miguel J, Paiva B, Mart\u00edn-S\u00e1nchez E.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39308023"},{"title01":"Teclistamab for relapsed refractory multiple myeloma patients on dialysis","title02":"Teclistamab for relapsed refractory multiple myeloma patients on dialysis","journal":"Br J Haematol","issue":"2024 Sep 14. doi: 10.1111\/bjh.19772. Online ahead of print.","author":"Lebreton P, Lachenal F, Bouillie S, Pica GM, Aftisse H, Pascal L, Montes L, Macro M, Johnson N, Harel S, Fernandez M, De Renzis B, Lioure B, Lazareth A, Javelot M, Louni C, Huart A, Perrot A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39275880"},{"title01":"Impact of soluble BCMA and non-T-cell factors on refractoriness to BCMA-targeting T-cell engagers in multiple myeloma","title02":"Impact of soluble BCMA and non-T-cell factors on refractoriness to BCMA-targeting T-cell engagers in multiple myeloma","journal":"Blood","issue":"2024 Sep 25:blood.2024026212. doi: 10.1182\/blood.2024026212. Online ahead of print.","author":"Lee H, Durante MA, Skerget S, Vishwamitra D, Benaoudia S, Ahn S, Poorebrahim M, Barakat E, Jung D, Leblay N, Ziccheddu B, Diamond BT, Papadimitriou M, Cohen AD, Landgren O, Neri P, Maura F, Bahlis NJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39321344"},{"title01":"Dexamethasone dose intensity does not impact outcomes in newly diagnosed multiple myeloma: a secondary SWOG analysis","title02":"Dexamethasone dose intensity does not impact outcomes in newly diagnosed multiple myeloma: a secondary SWOG analysis","journal":"Blood","issue":"2024 Sep 25:blood.2024025939. doi: 10.1182\/blood.2024025939. Online ahead of print.","author":"Banerjee R, Sexton R, Cowan AJ, Rosenberg AS, Ailawadhi S, Rajkumar SV, Kumar SK, Dispenzieri A, Lonial S, Durie BGM, Richardson PG, Usmani SZ, Hoering A, Orlowski RZ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39321347"},{"title01":"Measurable Residual Disease by Mass Spectrometry and Next-Generation Flow to Assess Treatment Response in Myeloma","title02":"Measurable Residual Disease by Mass Spectrometry and Next-Generation Flow to Assess Treatment Response in Myeloma","journal":"Blood","issue":"2024 Sep 18:blood.2024024995. doi: 10.1182\/blood.2024024995. Online ahead of print.","author":"Puig N, Agullo Roca C, Sanfeliciano TC, Cedena MT, Mart\u00ednez-L\u00f3pez J, Oriol A, Blanchard MJ, R\u00edos-Tamayo R, I\u00f1igo Rodr\u00edguez B, Sureda A, Lakhwani S, de la Rubia Comos J, Gonzalez-Calle V, Caba\u00f1as V, Palomera L, Moraleda JMM, Bargay J, Castro S, Rosi\u00f1ol L, Blad\u00e9 J, San-Miguel JF, Lahuerta JJ, Paiva B, Mateos MV.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39293025"},{"title01":"Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease","title02":"Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease","journal":"N Engl J Med","issue":"2024 Sep 19;391(11):1002-1014.","author":"Wolff D, Cutler C, Lee SJ, Pusic I, Bittencourt H, White J, Hamadani M, Arai S, Salhotra A, Perez-Simon JA, Alousi A, Choe H, Kwon M, Berm\u00fadez A, Kim I, Soci\u00e9 G, Chhabra S, Radojcic V, O'Toole T, Tian C, Ordentlich P, DeFilipp Z, Kitko CL; AGAVE-201 Investigators.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39292927"},{"title01":"Targeting CSF1R in Chronic GVHD – Lessons in Translation","title02":"Targeting CSF1R in Chronic GVHD – Lessons in Translation","journal":"N Engl J Med","issue":"2024 Sep 19;391(11):1053-1055.","author":"Sarantopoulos S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39292932"},{"title01":"CSF1R Blockade for Refractory Chronic Graft-versus-Host Disease","title02":"CSF1R Blockade for Refractory Chronic Graft-versus-Host Disease","journal":"N Engl J Med","issue":"2024 Sep 19;391(11):1055-1059.","author":"Mohty M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39292933"},{"title01":"Transplantation and long-term overall survival in acute myeloid leukaemia","title02":"Transplantation and long-term overall survival in acute myeloid leukaemia","journal":"Lancet Haematol","issue":"2024 Sep 20:S2352-3026(24)00274-6. doi: 10.1016\/S2352-3026(24)00274-6. Online ahead of print.","author":"Perusini MA, Yee KWL.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39312919"},{"title01":"Venetoclax plus decitabine as a bridge to allogeneic haematopoietic stem-cell transplantation in older patients with acute myeloid leukaemia (VEN-DEC GITMO): final report of a multicentre, single-arm, phase 2 trial","title02":"Venetoclax plus decitabine as a bridge to allogeneic haematopoietic stem-cell transplantation in older patients with acute myeloid leukaemia (VEN-DEC GITMO): final report of a multicentre, single-arm, phase 2 trial","journal":"Lancet Haematol","issue":"2024 Sep 20:S2352-3026(24)00241-2. doi: 10.1016\/S2352-3026(24)00241-2. Online ahead of print.","author":"Russo D, Polverelli N, Bernardi S, Santarone S, Farina M, Borlenghi E, Onida F, Castagna L, Bramanti S, Carella AM, Sorasio R, Martino M, Alati C, Olivieri A, Beltrami G, Curti A, Vetro C, Leotta S, Mancini V, Terruzzi E, Bernardi M, Galieni P, Musto P, Cerretti R, Giaccone L, Skert C, Radici V, Vezzoli M, Calza S, Leoni A, Garuffo L, Bonvicini C, Pellizzeri S, Malagola M, Ciceri F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39312920"},{"title01":"Sexual health-related psychological and emotional life after allogeneic haematopoietic stem-cell transplantation","title02":"Sexual health-related psychological and emotional life after allogeneic haematopoietic stem-cell transplantation","journal":"Lancet Haematol","issue":"2024 Sep 16:S2352-3026(24)00209-6. doi: 10.1016\/S2352-3026(24)00209-6. Online ahead of print.","author":"Alsuliman T, Alasadi L, Polomeni A, Capes A, Peric Z, Linke A, Schoemans H, Malard F, Chalandon Y, Mohty M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39312922"},{"title01":"Let’s talk about sex and haematopoietic stem-cell transplantation","title02":"Let’s talk about sex and haematopoietic stem-cell transplantation","journal":"Lancet Haematol","issue":"2024 Sep 16:S2352-3026(24)00270-9. doi: 10.1016\/S2352-3026(24)00270-9. Online ahead of print.","author":"Linke A, Del Castillo J, Scheffel K, Feenstra P, Manninen RL.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39312923"},{"title01":"Liver transplantation in metastatic colorectal cancer: a new standard of care?","title02":"Liver transplantation in metastatic colorectal cancer: a new standard of care?","journal":"Lancet","issue":"2024 Sep 21;404(10458):1078-1079.","author":"Heinemann V, Stintzing S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39306454"},{"title01":"Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): results from a multicentre, open-label, prospective, randomised controlled trial","title02":"Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): results from a multicentre, open-label, prospective, randomised controlled trial","journal":"Lancet","issue":"2024 Sep 21;404(10458):1107-1118.","author":"Adam R, Piedvache C, Chiche L, Adam JP, Salam\u00e9 E, Bucur P, Cherqui D, Scatton O, Granger V, Ducreux M, Cillo U, Cauchy F, Mabrut JY, Verslype C, Coubeau L, Hardwigsen J, Boleslawski E, Muscari F, Jeddou H, Pezet D, Heyd B, Lucidi V, Geboes K, Lerut J, Majno P, Grimaldi L, Levi F, Lewin M, Gelli M; Collaborative TransMet group.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39306468"},{"title01":"Randomized Phase III SIERRA Trial of (131)I-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed\/Refractory AML","title02":"Randomized Phase III SIERRA Trial of (131)I-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed\/Refractory AML","journal":"J Clin Oncol","issue":"2024 Sep 19:JCO2302018. doi: 10.1200\/JCO.23.02018. Online ahead of print.","author":"Gyurkocza B, Nath R, Seropian S, Choe H, Litzow MR, Abboud C, Koshy N, Stiff P, Tomlinson B, Abhyankar S, Foran J, Hari P, Chen G, Al-Kadhimi Z, Kebriaei P, Sabloff M, Orozco JJ, Jamieson K, Silverman M, Van Besien K, Schuster M, Law AD, Larkin K, Pandit-Taskar N, Rowley SD, Munshi P, Cook R, Levy MY, Lazarus HM, Sandmaier BM, Pagel JM, Reddy V, MacDougall J, McNamara K, Spross J, Haeuber E, Vusirikala M, Nahar A, Desai A, Giralt S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39298738"},{"title01":"Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma)","title02":"Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma)","journal":"J Clin Oncol","issue":"2024 Sep 13:JCO2400554. doi: 10.1200\/JCO.24.00554. Online ahead of print.","author":"Tournilhac O, Altmann B, Friedrichs B, Bouabdallah K, Leclerc M, Cartron G, Turlure P, Reimer P, Wagner-Drouet E, Sanhes L, Houot R, Roussel M, Kroschinsky F, Dreger P, Viardot A, de Leval L, Rosenwald A, Gaulard P, Wulf G, Villate A, Latiere C, Elmaagacli A, Glass B, Poeschel V, Damaj G, Sibon D, Durot E, Bilger K, Banos A, Haenel M, Dreyling M, Keller U, Tiab M, Drenou B, Cornillon J, Nguyen S, Robin M, Nickelsen M, Tr\u00fcmper L, Lenz G, Ziepert M, Schmitz N; French Lymphoma Study Association (LYSA); Soci\u00e9t\u00e9 Francophone de greffe de moelle et Th\u00e9rapie Cellulaire (SFGM-TC); German Lymphoma Alliance (GLA); French Lymphoma Study Association (LYSA), Soci\u00e9t\u00e9 Francophone de greffe de moelle et Th\u00e9rapie Cellulaire (SFGM-TC), German Lymphoma Alliance (GLA).","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39270145"},{"title01":"Susceptibility to BK polyomavirus-associated hemorrhagic cystitis in children undergoing allogeneic transplant","title02":"Susceptibility to BK polyomavirus-associated hemorrhagic cystitis in children undergoing allogeneic transplant","journal":"Haematologica","issue":"2024 Sep 19. doi: 10.3324\/haematol.2024.286163. Online ahead of print.","author":"Abdullah S, Sabulski A, Hudda Z, Ziady A, Luebbering N, Giordullo L, Odegard E, Blackard JT, Kleiboeker S, Altrich M, Jodele S, Seif AE, Davies SM, Laskin BL.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39295420"},{"title01":"Immune reconstitution dynamics after unrelated allogeneic transplantation with post-transplant cyclophosphamide compared to classical immunosuppression with anti-thymocyte globulin: a prospective cohort study","title02":"Immune reconstitution dynamics after unrelated allogeneic transplantation with post-transplant cyclophosphamide compared to classical immunosuppression with anti-thymocyte globulin: a prospective cohort study","journal":"Haematologica","issue":"2024 Sep 12. doi: 10.3324\/haematol.2024.285921. Online ahead of print.","author":"Kerbauy MN, Rocha FA, Arcuri LJ, Cunegundes PS, Kerbauy LN, Machado CM, Ribeiro AAF, Banerjee PP, Marti LC, Hamerschlak N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39279428"},{"title01":"A randomized trial of ibrutinib and R-GDP prior to stem cell transplant in relapsed diffuse large B-cell lymphoma","title02":"A randomized trial of ibrutinib and R-GDP prior to stem cell transplant in relapsed diffuse large B-cell lymphoma","journal":"Br J Haematol","issue":"2024 Sep 12. doi: 10.1111\/bjh.19764. Online ahead of print.","author":"Kuruvilla J, Rushton C, Villa D, Aslam M, Prica A, Abdel Samad N, Doucet S, Dudebout J, Fleury I, Fraser G, Larouche JF, Shafey M, Skrabek P, Skamene T, Morin RD, Alcaide M, Ben-Neriah S, Lee D, Winch C, Shepherd LE, Scott DW, Crump M, Chen BE, Hay AE.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39267295"},{"title01":"Novel finding of vaccine-derived rubella virus-associated granulomata in an adult patient post-allogeneic haematopoietic stem cell transplant","title02":"Novel finding of vaccine-derived rubella virus-associated granulomata in an adult patient post-allogeneic haematopoietic stem cell transplant","journal":"Br J Haematol","issue":"2024 Sep 15. doi: 10.1111\/bjh.19762. Online ahead of print.","author":"Durity E, Zheng J, Sanchez E, Donati M, Perry K, Derrick J, Taylor A, Fink C, Holden J, Grant P, Byott M, Rickaby W, Asher N, Walker SL, Thomson K, Bunker C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39279194"},{"title01":"A critical review of management of allogeneic transplant-eligible adults with Ph+ acute lymphoblastic leukaemia","title02":"A critical review of management of allogeneic transplant-eligible adults with Ph+ acute lymphoblastic leukaemia","journal":"Br J Haematol","issue":"2024 Sep 17. doi: 10.1111\/bjh.19682. Online ahead of print.","author":"Shanmuganathan N, Grigg A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39289867"},{"title01":"Transplant outcome in pediatric Fanconi anemia","title02":"Transplant outcome in pediatric Fanconi anemia","journal":"Blood","issue":"2024 Sep 19;144(12):1350.","author":"No authors listed","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39298164"},{"title01":"USP4 regulates ribosome biogenesis and protein synthesis for hematopoietic stem cell regeneration and leukemia progression","title02":"USP4 regulates ribosome biogenesis and protein synthesis for hematopoietic stem cell regeneration and leukemia progression","journal":"Leukemia","issue":"2024 Sep 12. doi: 10.1038\/s41375-024-02338-z. Online ahead of print.","author":"Liu B, Zhang X, Zhou Y, Liu H, Wang Z, Fu Y, Gao Q, Cheng X, Sun Q, Ju Z.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39266638"},{"title01":"Venetoclax plus decitabine as a bridge to allogeneic haematopoietic stem-cell transplantation in older patients with acute myeloid leukaemia (VEN-DEC GITMO): final report of a multicentre, single-arm, phase 2 trial","title02":"Venetoclax plus decitabine as a bridge to allogeneic haematopoietic stem-cell transplantation in older patients with acute myeloid leukaemia (VEN-DEC GITMO): final report of a multicentre, single-arm, phase 2 trial","journal":"Lancet Haematol","issue":"2024 Sep 20:S2352-3026(24)00241-2. doi: 10.1016\/S2352-3026(24)00241-2. Online ahead of print.","author":"Russo D, Polverelli N, Bernardi S, Santarone S, Farina M, Borlenghi E, Onida F, Castagna L, Bramanti S, Carella AM, Sorasio R, Martino M, Alati C, Olivieri A, Beltrami G, Curti A, Vetro C, Leotta S, Mancini V, Terruzzi E, Bernardi M, Galieni P, Musto P, Cerretti R, Giaccone L, Skert C, Radici V, Vezzoli M, Calza S, Leoni A, Garuffo L, Bonvicini C, Pellizzeri S, Malagola M, Ciceri F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39312920"},{"title01":"Sexual health-related psychological and emotional life after allogeneic haematopoietic stem-cell transplantation","title02":"Sexual health-related psychological and emotional life after allogeneic haematopoietic stem-cell transplantation","journal":"Lancet Haematol","issue":"2024 Sep 16:S2352-3026(24)00209-6. doi: 10.1016\/S2352-3026(24)00209-6. Online ahead of print.","author":"Alsuliman T, Alasadi L, Polomeni A, Capes A, Peric Z, Linke A, Schoemans H, Malard F, Chalandon Y, Mohty M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39312922"},{"title01":"Let’s talk about sex and haematopoietic stem-cell transplantation","title02":"Let’s talk about sex and haematopoietic stem-cell transplantation","journal":"Lancet Haematol","issue":"2024 Sep 16:S2352-3026(24)00270-9. doi: 10.1016\/S2352-3026(24)00270-9. Online ahead of print.","author":"Linke A, Del Castillo J, Scheffel K, Feenstra P, Manninen RL.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39312923"},{"title01":"Randomized Phase III SIERRA Trial of (131)I-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed\/Refractory AML","title02":"Randomized Phase III SIERRA Trial of (131)I-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed\/Refractory AML","journal":"J Clin Oncol","issue":"2024 Sep 19:JCO2302018. doi: 10.1200\/JCO.23.02018. Online ahead of print.","author":"Gyurkocza B, Nath R, Seropian S, Choe H, Litzow MR, Abboud C, Koshy N, Stiff P, Tomlinson B, Abhyankar S, Foran J, Hari P, Chen G, Al-Kadhimi Z, Kebriaei P, Sabloff M, Orozco JJ, Jamieson K, Silverman M, Van Besien K, Schuster M, Law AD, Larkin K, Pandit-Taskar N, Rowley SD, Munshi P, Cook R, Levy MY, Lazarus HM, Sandmaier BM, Pagel JM, Reddy V, MacDougall J, McNamara K, Spross J, Haeuber E, Vusirikala M, Nahar A, Desai A, Giralt S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39298738"},{"title01":"Re-vaccination against SARS-CoV-2 in allogeneic HSCT patients: Repeated primary vaccine doses increase seroconversion rates","title02":"Re-vaccination against SARS-CoV-2 in allogeneic HSCT patients: Repeated primary vaccine doses increase seroconversion rates","journal":"Br J Haematol","issue":"2024 Sep 23. doi: 10.1111\/bjh.19780. Online ahead of print.","author":"Tsoutsoukis M, Anthias C, Easdale S, Nicholson E.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39313909"},{"title01":"A randomized trial of ibrutinib and R-GDP prior to stem cell transplant in relapsed diffuse large B-cell lymphoma","title02":"A randomized trial of ibrutinib and R-GDP prior to stem cell transplant in relapsed diffuse large B-cell lymphoma","journal":"Br J Haematol","issue":"2024 Sep 12. doi: 10.1111\/bjh.19764. Online ahead of print.","author":"Kuruvilla J, Rushton C, Villa D, Aslam M, Prica A, Abdel Samad N, Doucet S, Dudebout J, Fleury I, Fraser G, Larouche JF, Shafey M, Skrabek P, Skamene T, Morin RD, Alcaide M, Ben-Neriah S, Lee D, Winch C, Shepherd LE, Scott DW, Crump M, Chen BE, Hay AE.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39267295"},{"title01":"MERTK inhibition selectively activates a DC – T-cell axis to provide anti-leukemia immunity","title02":"MERTK inhibition selectively activates a DC – T-cell axis to provide anti-leukemia immunity","journal":"Leukemia","issue":"2024 Sep 25. doi: 10.1038\/s41375-024-02408-2. Online ahead of print.","author":"Huelse JM, Bhasin SS, Jacobsen KM, Yim J, Thomas BE, Branella GM, Bakhtiari M, Chimenti ML, Baxter TA, Raikar SS, Wang X, Frye SV, Henry CJ, Earp HS, Bhasin M, DeRyckere D, Graham DK.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39322710"},{"title01":"Oral decitabine-cedazuridine in acute myeloid leukaemia","title02":"Oral decitabine-cedazuridine in acute myeloid leukaemia","journal":"Br J Haematol","issue":"2024 Sep 23. doi: 10.1111\/bjh.19769. Online ahead of print.","author":"Bouligny IM, DiNardo CD.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39313925"},{"title01":"Leucocytosis during all-trans retinoic acid and arsenic trioxide treatment in acute promyelocytic leukaemia","title02":"Leucocytosis during all-trans retinoic acid and arsenic trioxide treatment in acute promyelocytic leukaemia","journal":"Br J Haematol","issue":"2024 Sep 15. doi: 10.1111\/bjh.19763. Online ahead of print.","author":"Yanada M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39279289"},{"title01":"Phase 3 study of gilteritinib versus salvage chemotherapy in predominantly Asian patients with relapsed\/refractory FLT3-mutated acute myeloid leukemia","title02":"Phase 3 study of gilteritinib versus salvage chemotherapy in predominantly Asian patients with relapsed\/refractory FLT3<\/i>-mutated acute myeloid leukemia","journal":"Leukemia","issue":"2024 Sep 5. doi: 10.1038\/s41375-024-02382-9. Online ahead of print.","author":"Wang J, Jiang B, Li J, Liu L, Du X, Jiang H, Hu J, Yuan M, Sakatani T, Kadokura T, Takeuchi M, Kosako M, Ma X, Girshova L, Tan J, Bondarenko S, Lee LWL, Khuhapinant A, Martynova E, Hasabou N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39237634"},{"title01":"The non-canonical BAF chromatin remodeling complex is a novel target of spliceosome dysregulation in SF3B1-mutated chronic lymphocytic leukemia","title02":"The non-canonical BAF chromatin remodeling complex is a novel target of spliceosome dysregulation in SF3B1<\/i>-mutated chronic lymphocytic leukemia","journal":"Leukemia","issue":"2024 Sep 11. doi: 10.1038\/s41375-024-02379-4. Online ahead of print.","author":"H\u00e4gerstrand D, Oder B, Cortese D, Qu Y, Binzer-Panchal A, \u00d6sterholm C, Del Peso Santos T, Rabbani L, Asl HF, Skaftason A, Ljungstr\u00f6m V, Lundholm A, Koutroumani M, Haider Z, Jylh\u00e4 C, Mollstedt J, Mansouri L, Plevova K, Agathangelidis A, Scarf\u00f2 L, Armand M, Muggen AF, Kay NE, Shanafelt T, Rossi D, Orre LM, Pospisilova S, Barylyuk K, Davi F, Vesterlund M, Langerak AW, Lehti\u00f6 J, Ghia P, Stamatopoulos K, Sutton LA, Rosenquist R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39261602"},{"title01":"Adverse prognostic impact of KIT exon 17 mutations despite negative flow cytometric measurable residual disease in pediatric acute myeloid leukemia with RUNX1::RUNX1T1","title02":"Adverse prognostic impact of KIT<\/i> exon 17 mutations despite negative flow cytometric measurable residual disease in pediatric acute myeloid leukemia with RUNX1::RUNX1T1<\/i>","journal":"Haematologica","issue":"2024 Sep 5. doi: 10.3324\/haematol.2024.286243. Online ahead of print.","author":"Kato S, Tsujimoto SI, Matsubayashi J, Iwamoto S, Hiramatsu H, Okuno Y, Kamitori T, Ohki K, Deguchi T, Kiyokawa N, Kato M, Takita J, Tanaka S, Adachi S, Tomizawa D, Shiba N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39234860"},{"title01":"Entities versus diseases: Myers et al. propose distinct aspects of adult T-cell lymphoma\/leukemia","title02":"Entities versus<\/i> diseases: Myers et al.<\/i> propose distinct aspects of adult T-cell lymphoma\/leukemia","journal":"Haematologica","issue":"2024 Aug 29. doi: 10.3324\/haematol.2024.286174. Online ahead of print.","author":"Pileri SA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39219497"},{"title01":"The discovery of NPM1 mutations in acute myeloid leukemia","title02":"The discovery of NPM1<\/i> mutations in acute myeloid leukemia","journal":"Haematologica","issue":"2024 Sep 1;109(9):2753-2755.","author":"Sportoletti P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39221510"},{"title01":"Entities versus diseases: Myers et al. propose distinct aspects of adult T-cell lymphoma\/leukemia","title02":"Entities versus<\/i> diseases: Myers et al.<\/i> propose distinct aspects of adult T-cell lymphoma\/leukemia","journal":"Haematologica","issue":"2024 Aug 29. doi: 10.3324\/haematol.2024.286174. Online ahead of print.","author":"Pileri SA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39219497"},{"title01":"Evaluation of coverage, generalisability and validity of the U-CAN lymphoma biobank in Sweden: A comparison with nationwide registers","title02":"Evaluation of coverage, generalisability and validity of the U-CAN lymphoma biobank in Sweden: A comparison with nationwide registers","journal":"Br J Haematol","issue":"2024 Sep 3. doi: 10.1111\/bjh.19732. Online ahead of print.","author":"Forsgren E, Ekberg S, Smedby KE, Nylund P, Sj\u00f6blom T, Flogeg\u00e5rd M, Sj\u00f6str\u00f6m S, Hultdin M, Hall\u00e9n K, Hellstr\u00f6m M, Molin D, Enblad G, Glimelius I.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39228094"},{"title01":"Baseline Immune State and T-cell Clonal Kinetics are Associated with Durable Response to CAR-T Therapy in Large B-cell Lymphoma","title02":"Baseline Immune State and T-cell Clonal Kinetics are Associated with Durable Response to CAR-T Therapy in Large B-cell Lymphoma","journal":"Blood","issue":"2024 Sep 6:blood.2024024381. doi: 10.1182\/blood.2024024381. Online ahead of print.","author":"Maurer K, Grabski IN, Houot R, Gohil SH, Miura S, Redd RA, Lyu H, Lu W, Arihara Y, Budka J, McDonough M, Ansuinelli M, Reynolds CG, Jacene H, Li S, Livak KJ, Ritz J, Miles B, Mattie M, Neuberg DS, Irizarry RA, Armand P, Wu CJ, Jacobson CA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39241199"},{"title01":"Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO Cohort Study analysis","title02":"Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO Cohort Study analysis","journal":"Blood","issue":"2024 Sep 10:blood.2024025681. doi: 10.1182\/blood.2024025681. Online ahead of print.","author":"Abro B, Maurer MJ, Habermann TM, Burack R, Chapman JR, Cohen JB, Friedberg JW, Inghirami GG, Kahl BS, Larson MC, Link BL, Lossos IS, Martin P, McDonnell T, Nastoupil LJ, Riska S, Syrbu SI, Vega F, Vij K, Flowers CR, Cerhan JR, Jaye DL, Feldman AL.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39255410"},{"title01":"Circulating composite B- and T-cell lymphoma","title02":"Circulating composite B- and T-cell lymphoma","journal":"Blood","issue":"2024 Aug 29;144(9):1027.","author":"Zhou Q, Chang H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39207813"},{"title01":"New insights into the biology of T-cell lymphomas","title02":"New insights into the biology of T-cell lymphomas","journal":"Blood","issue":"2024 Aug 30:blood.2023021787. doi: 10.1182\/blood.2023021787. Online ahead of print.","author":"Iqbal J, Inghirami GG, Chan WC.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39213420"},{"title01":"IL-10R inhibition reprograms tumor-associated macrophages and reverses drug resistance in multiple myeloma","title02":"IL-10R inhibition reprograms tumor-associated macrophages and reverses drug resistance in multiple myeloma","journal":"Leukemia","issue":"2024 Aug 30. doi: 10.1038\/s41375-024-02391-8. Online ahead of print.","author":"Sun J, Corradini S, Azab F, Shokeen M, Muz B, Miari KE, Maksimos M, Diedrich C, Asare O, Alhallak K, Park C, Lubben B, Chen Y, Adebayo O, Bash H, Kelley S, Fiala M, Bender DE, Zhou H, Wang S, Vij R, Williams MTS, Azab AK.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39215060"},{"title01":"Mosaic chromosomal alterations in hematopoietic cells and clinical outcomes in patients with multiple myeloma","title02":"Mosaic chromosomal alterations in hematopoietic cells and clinical outcomes in patients with multiple myeloma","journal":"Leukemia","issue":"2024 Sep 2. doi: 10.1038\/s41375-024-02396-3. Online ahead of print.","author":"Husby S, Tulstrup M, Harsl\u00f8f M, Nielsen C, Haastrup E, Ebbesen LH, Klarskov Andersen M, Pertesi M, Brieghel C, Niemann CU, Nilsson B, Szabo AG, Andersen NF, Abildgaard N, Vangsted A, Gr\u00f8nb\u00e6k K.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39223296"},{"title01":"Ixazomib as consolidation and maintenance versus observation in patients with relapsed multiple myeloma eligible for salvage autologous stem-cell transplantation (Myeloma XII [ACCoRD]): interim analysis of a multicentre, open-label, randomised, phase 3 trial","title02":"Ixazomib as consolidation and maintenance versus observation in patients with relapsed multiple myeloma eligible for salvage autologous stem-cell transplantation (Myeloma XII [ACCoRD]): interim analysis of a multicentre, open-label, randomised, phase 3 trial","journal":"Lancet Haematol","issue":"2024 Sep 6:S2352-3026(24)00249-7. doi: 10.1016\/S2352-3026(24)00249-7. Online ahead of print.","author":"Cook G, Ashcroft AJ, Senior E, Olivier C, Hockaday A, Richards J, Cavenagh JD, Snowden JA, Drayson MT, de Tute R, Roberts L, Owen RG, Yong K, Garg M, Boyd K, Sati H, Gillson S, Cook M, Cairns DA, Parrish C; United Kingdom Myeloma Research Alliance.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39250926"},{"title01":"Continued need for autologous transplantation in relapsed myeloma","title02":"Continued need for autologous transplantation in relapsed myeloma","journal":"Lancet Haematol","issue":"2024 Sep 6:S2352-3026(24)00277-1. doi: 10.1016\/S2352-3026(24)00277-1. Online ahead of print.","author":"Mai EK.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39250927"},{"title01":"Leukaemia, lymphoma, and multiple myeloma mortality after low-level exposure to ionising radiation in nuclear workers (INWORKS): updated findings from an international cohort study","title02":"Leukaemia, lymphoma, and multiple myeloma mortality after low-level exposure to ionising radiation in nuclear workers (INWORKS): updated findings from an international cohort study","journal":"Lancet Haematol","issue":"2024 Aug 30:S2352-3026(24)00240-0. doi: 10.1016\/S2352-3026(24)00240-0. Online ahead of print.","author":"Leuraud K, Laurier D, Gillies M, Haylock R, Kelly-Reif K, Bertke S, Daniels RD, Thierry-Chef I, Moissonnier M, Kesminiene A, Schubauer-Berigan MK, Richardson DB.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39222647"},{"title01":"Comparing the clinical trial efficacy versus real-world effectiveness of treatments for multiple myeloma: a population-based study","title02":"Comparing the clinical trial efficacy versus<\/i> real-world effectiveness of treatments for multiple myeloma: a population-based study","journal":"Haematologica","issue":"2024 Aug 22. doi: 10.3324\/haematol.2024.285768. Online ahead of print.","author":"Visram A, Chan KK, Seow H, Pond G, Gayowsky A, Mohyuddin GR, McCurdy A, Sandhu I, Venner C, Lancman G, Balitsky A, Kouroukis T, Bruins R, Kumar S, Fonseca R, Mian H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39219457"},{"title01":"AURKA targeting: a NEAT approach to halt myeloma","title02":"AURKA targeting: a NEAT approach to halt myeloma","journal":"Haematologica","issue":"2024 Aug 29. doi: 10.3324\/haematol.2024.286085. Online ahead of print.","author":"Solimando AG, Botta C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39219507"},{"title01":"Induction prior to autologous haematopoietic cell transplantation in multiple myeloma","title02":"Induction prior to autologous haematopoietic cell transplantation in multiple myeloma","journal":"Br J Haematol","issue":"2024 Sep 9. doi: 10.1111\/bjh.19753. Online ahead of print.","author":"Mohty M, Malard F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39248117"},{"title01":"Advanced imaging for earlier diagnosis and morbidity prevention in multiple myeloma: A British Society of Haematology and UK Myeloma Society Good Practice Paper","title02":"Advanced imaging for earlier diagnosis and morbidity prevention in multiple myeloma: A British Society of Haematology and UK Myeloma Society Good Practice Paper","journal":"Br J Haematol","issue":"2024 Sep 9. doi: 10.1111\/bjh.19716. Online ahead of print.","author":"Kaiser M, Goh V, Stern S, Spencer N, Rabin N, Ramasamy K, Lawless S, Soutar R, Ashcroft J, Pratt G, Messiou C, Bygrave C; BSH Committee.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39248274"},{"title01":"Metformin augments GPRC5D in multiple myeloma and enhances the efficacy of GPRC5D-CAR T cells","title02":"Metformin augments GPRC5D in multiple myeloma and enhances the efficacy of GPRC5D-CAR T cells","journal":"Br J Haematol","issue":"2024 Sep 3. doi: 10.1111\/bjh.19739. Online ahead of print.","author":"Hu X, Zhou X, Zhao Q, Yang Y, Liang Y, Xiao Y, Liu Z, Liu L, Zhang C, Du J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39228074"},{"title01":"Erdheim-Chester disease in a patient with multiple myeloma","title02":"Erdheim-Chester disease in a patient with multiple myeloma","journal":"Blood","issue":"2024 Sep 5;144(10):1131.","author":"Parsee AA, Li JY.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39235797"},{"title01":"Ide-cel vs standard regimens in triple-class-exposed relapsed and refractory multiple myeloma: updated KarMMa-3 analyses","title02":"Ide-cel vs standard regimens in triple-class-exposed relapsed and refractory multiple myeloma: updated KarMMa-3 analyses","journal":"Blood","issue":"2024 Aug 28:blood.2024024582. doi: 10.1182\/blood.2024024582. Online ahead of print.","author":"Ailawadhi S, Arnulf B, Patel KK, Cavo M, Nooka AK, Manier S, Callander NS, Costa LJ, Vij R, Bahlis NJ, Moreau P, Solomon SR, Abrahamsen IW, Baz RC, Broijl A, Chen C, Jagannath S, Raje N, Scheid C, Delforge M, Benjamin R, Pabst T, Iida S, Berdeja JG, Giralt SA, Truppel-Hartmann A, Chen Y, Zhong X, Wu F, Piasecki J, Eliason L, Dhanda DS, Felten J, Caia A, Cook M, Popa-Mckiver M, Rodriguez-Otero P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39197072"},{"title01":"Ixazomib as consolidation and maintenance versus observation in patients with relapsed multiple myeloma eligible for salvage autologous stem-cell transplantation (Myeloma XII [ACCoRD]): interim analysis of a multicentre, open-label, randomised, phase 3 trial","title02":"Ixazomib as consolidation and maintenance versus observation in patients with relapsed multiple myeloma eligible for salvage autologous stem-cell transplantation (Myeloma XII [ACCoRD]): interim analysis of a multicentre, open-label, randomised, phase 3 trial","journal":"Lancet Haematol","issue":"2024 Sep 6:S2352-3026(24)00249-7. doi: 10.1016\/S2352-3026(24)00249-7. Online ahead of print.","author":"Cook G, Ashcroft AJ, Senior E, Olivier C, Hockaday A, Richards J, Cavenagh JD, Snowden JA, Drayson MT, de Tute R, Roberts L, Owen RG, Yong K, Garg M, Boyd K, Sati H, Gillson S, Cook M, Cairns DA, Parrish C; United Kingdom Myeloma Research Alliance.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39250926"},{"title01":"Continued need for autologous transplantation in relapsed myeloma","title02":"Continued need for autologous transplantation in relapsed myeloma","journal":"Lancet Haematol","issue":"2024 Sep 6:S2352-3026(24)00277-1. doi: 10.1016\/S2352-3026(24)00277-1. Online ahead of print.","author":"Mai EK.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39250927"},{"title01":"Blinatumomab is associated with better post-transplant outcome than chemotherapy in children with high-risk first-relapse B-cell acute lymphoblastic leukemia irrespective of the conditioning regimen","title02":"Blinatumomab is associated with better post-transplant outcome than chemotherapy in children with high-risk first-relapse B-cell acute lymphoblastic leukemia irrespective of the conditioning regimen","journal":"Haematologica","issue":"2024 Sep 5. doi: 10.3324\/haematol.2024.285837. Online ahead of print.","author":"Peters C, Bruno A, Rizzari C, Brescianini A, Von Stackelberg A, Linderkamp C, Zeng Y, Zugmaier G, Locatelli F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39234873"},{"title01":"Utilization of allogeneic hematopoietic stem cell transplantation among patients with newly diagnosed acute myeloid leukemia in California: a population-based linked dataset study","title02":"Utilization of allogeneic hematopoietic stem cell transplantation among patients with newly diagnosed acute myeloid leukemia in California: a population-based linked dataset study","journal":"Haematologica","issue":"2024 Aug 29. doi: 10.3324\/haematol.2024.285648. Online ahead of print.","author":"Meyer CL, Keegan THM, Brunson A, Auletta JJ, Morton LM, Wun T, Schonfeld SJ, Valcarcel B, Abrah\u00e3o R, Yusuf RA, Muffly L.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39219504"},{"title01":"Hybrid allogeneic bone marrow transplant rescue approach after acute myelogenous leukaemia relapse in a high-risk patient","title02":"Hybrid allogeneic bone marrow transplant rescue approach after acute myelogenous leukaemia relapse in a high-risk patient","journal":"Br J Haematol","issue":"2024 Sep 5. doi: 10.1111\/bjh.19749. Online ahead of print.","author":"Villar-Prados A, Kennedy VE, Meyer EH.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39238111"},{"title01":"Induction prior to autologous haematopoietic cell transplantation in multiple myeloma","title02":"Induction prior to autologous haematopoietic cell transplantation in multiple myeloma","journal":"Br J Haematol","issue":"2024 Sep 9. doi: 10.1111\/bjh.19753. Online ahead of print.","author":"Mohty M, Malard F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39248117"},{"title01":"Mosaic chromosomal alterations in hematopoietic cells and clinical outcomes in patients with multiple myeloma","title02":"Mosaic chromosomal alterations in hematopoietic cells and clinical outcomes in patients with multiple myeloma","journal":"Leukemia","issue":"2024 Sep 2. doi: 10.1038\/s41375-024-02396-3. Online ahead of print.","author":"Husby S, Tulstrup M, Harsl\u00f8f M, Nielsen C, Haastrup E, Ebbesen LH, Klarskov Andersen M, Pertesi M, Brieghel C, Niemann CU, Nilsson B, Szabo AG, Andersen NF, Abildgaard N, Vangsted A, Gr\u00f8nb\u00e6k K.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39223296"},{"title01":"Ixazomib as consolidation and maintenance versus observation in patients with relapsed multiple myeloma eligible for salvage autologous stem-cell transplantation (Myeloma XII [ACCoRD]): interim analysis of a multicentre, open-label, randomised, phase 3 trial","title02":"Ixazomib as consolidation and maintenance versus observation in patients with relapsed multiple myeloma eligible for salvage autologous stem-cell transplantation (Myeloma XII [ACCoRD]): interim analysis of a multicentre, open-label, randomised, phase 3 trial","journal":"Lancet Haematol","issue":"2024 Sep 6:S2352-3026(24)00249-7. doi: 10.1016\/S2352-3026(24)00249-7. Online ahead of print.","author":"Cook G, Ashcroft AJ, Senior E, Olivier C, Hockaday A, Richards J, Cavenagh JD, Snowden JA, Drayson MT, de Tute R, Roberts L, Owen RG, Yong K, Garg M, Boyd K, Sati H, Gillson S, Cook M, Cairns DA, Parrish C; United Kingdom Myeloma Research Alliance.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39250926"},{"title01":"Utilization of allogeneic hematopoietic stem cell transplantation among patients with newly diagnosed acute myeloid leukemia in California: a population-based linked dataset study","title02":"Utilization of allogeneic hematopoietic stem cell transplantation among patients with newly diagnosed acute myeloid leukemia in California: a population-based linked dataset study","journal":"Haematologica","issue":"2024 Aug 29. doi: 10.3324\/haematol.2024.285648. Online ahead of print.","author":"Meyer CL, Keegan THM, Brunson A, Auletta JJ, Morton LM, Wun T, Schonfeld SJ, Valcarcel B, Abrah\u00e3o R, Yusuf RA, Muffly L.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39219504"},{"title01":"Induction prior to autologous haematopoietic cell transplantation in multiple myeloma","title02":"Induction prior to autologous haematopoietic cell transplantation in multiple myeloma","journal":"Br J Haematol","issue":"2024 Sep 9. doi: 10.1111\/bjh.19753. Online ahead of print.","author":"Mohty M, Malard F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39248117"},{"title01":"Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in Adults over 70 years old","title02":"Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in Adults over 70 years old","journal":"Blood","issue":"2024 Sep 6:blood.2024024247. doi: 10.1182\/blood.2024024247. Online ahead of print.","author":"Walter RB, Potter V, Craddock C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39241195"},{"title01":"Infection by Helicobacter pylori cytotoxin-A-associated antigen-positive strains is associated with iron deficiency anemia in a longitudinal birth cohort in Brazil","title02":"Infection by Helicobacter pylori<\/i> cytotoxin-A-associated antigen-positive strains is associated with iron deficiency anemia in a longitudinal birth cohort in Brazil","journal":"Haematologica","issue":"2024 Aug 22. doi: 10.3324\/haematol.2024.285446. Online ahead of print.","author":"Queiroz DMM, Braga LLC, Rocha GA, Batista SA, Rocha AMC, Saito M, Checkley W, Gilman RH, Crabtree JE.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39219459"},{"title01":"Association of biomarkers of endothelial function, coagulation activation and kidney injury with persistent albuminuria in sickle cell anaemia","title02":"Association of biomarkers of endothelial function, coagulation activation and kidney injury with persistent albuminuria in sickle cell anaemia","journal":"Br J Haematol","issue":"2024 Sep 3. doi: 10.1111\/bjh.19743. Online ahead of print.","author":"Elsherif L, Tang Y, Patillo KL, Wichlan D, Ogu UO, Landes K, McCune P, Scott LC, Gulledge W, Woodland WH, Nelson M, Loehr LR, Cronin RM, Desai PC, Zhou LY, Pollock DM, Zou F, Cai J, Derebail VK, Ataga KI.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39228027"},{"title01":"Integrating chemokines and machine learning algorithms for diagnosis and bleeding assessment in primary immune thrombocytopenia: A prospective cohort study","title02":"Integrating chemokines and machine learning algorithms for diagnosis and bleeding assessment in primary immune thrombocytopenia: A prospective cohort study","journal":"Br J Haematol","issue":"2024 Sep 10. doi: 10.1111\/bjh.19745. Online ahead of print.","author":"Wen Q, Sun T, Chen J, Li Y, Liu X, Li H, Fu R, Liu W, Xue F, Ju M, Dong H, Dai X, Wang W, Chi Y, Yang R, Chen Y, Zhang L.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39253817"},{"title01":"Is there a role for eltrombopag drug levels in paediatric immune thrombocytopenia management?","title02":"Is there a role for eltrombopag drug levels in paediatric immune thrombocytopenia management?","journal":"Br J Haematol","issue":"2024 Sep 3. doi: 10.1111\/bjh.19757. Online ahead of print.","author":"Lo C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39228082"},{"title01":"Cohesin mutations in acute myeloid leukemia","title02":"Cohesin mutations in acute myeloid leukemia","journal":"Leukemia","issue":"2024 Sep 9. doi: 10.1038\/s41375-024-02406-4. Online ahead of print.","author":"Boucher A, Murray J, Rao S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39251741"},{"title01":"Early-life tobacco exposure is causally implicated in aberrant RAG-mediated recombination in childhood acute lymphoblastic leukemia","title02":"Early-life tobacco exposure is causally implicated in aberrant RAG-mediated recombination in childhood acute lymphoblastic leukemia","journal":"Leukemia","issue":"2024 Sep 9. doi: 10.1038\/s41375-024-02407-3. Online ahead of print.","author":"Liu T, Xu K, Pardeshi A, Myint SS, Kang AY, Morimoto LM, Lieber MR, Wiemels JL, Kogan SC, Metayer C, de Smith AJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39251742"},{"title01":"Are measurable residual disease results after consolidation therapy useful in children with acute lymphoblastic leukemia?","title02":"Are measurable residual disease results after consolidation therapy useful in children with acute lymphoblastic leukemia?","journal":"Leukemia","issue":"2024 Sep 10. doi: 10.1038\/s41375-024-02386-5. Online ahead of print.","author":"Stutterheim J, van der Waarden R, de Groot-Kruseman HA, Sonneveld E, de Haas V, Dandis R, van der Schoot CE, van der Velden VHJ, Pieters R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39256602"},{"title01":"Determinants of survival after first relapse of acute lymphoblastic leukemia: a Children’s Oncology Group study","title02":"Determinants of survival after first relapse of acute lymphoblastic leukemia: a Children’s Oncology Group study","journal":"Leukemia","issue":"2024 Sep 11. doi: 10.1038\/s41375-024-02395-4. Online ahead of print.","author":"Rheingold SR, Bhojwani D, Ji L, Xu X, Devidas M, Kairalla JA, Shago M, Heerema NA, Carroll AJ, Breidenbach H, Borowitz M, Wood BL, Angiolillo AL, Asselin BL, Bowman WP, Brown P, Dreyer ZE, Dunsmore KP, Hilden JM, Larsen E, Maloney K, Matloub Y, Mattano LA, Winter SS, Gore L, Winick NJ, Carroll WL, Hunger SP, Raetz EA, Loh ML.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39261601"},{"title01":"CXCR4 as a therapeutic target in acute myeloid leukemia","title02":"CXCR4 as a therapeutic target in acute myeloid leukemia","journal":"Leukemia","issue":"2024 Sep 11. doi: 10.1038\/s41375-024-02326-3. Online ahead of print.","author":"Korbecki J, Bosiacki M, Kupnicka P, Barczak K, Chlubek D, Baranowska-Bosiacka I.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39261603"},{"title01":"Star wars against leukemia: attacking the clones","title02":"Star wars against leukemia: attacking the clones","journal":"Leukemia","issue":"2024 Sep 2. doi: 10.1038\/s41375-024-02369-6. Online ahead of print.","author":"Toma MM, Skorski T.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39223295"},{"title01":"Mutational mechanisms in multiply relapsed pediatric acute lymphoblastic leukemia","title02":"Mutational mechanisms in multiply relapsed pediatric acute lymphoblastic leukemia","journal":"Leukemia","issue":"2024 Sep 4. doi: 10.1038\/s41375-024-02403-7. Online ahead of print.","author":"van der Ham CG, Suurenbroek LC, Kleisman MM, Anti\u0107 \u017d, Lelieveld SH, Yeong M, Westera L, Sonneveld E, Hoogerbrugge PM, van der Velden VHJ, van Leeuwen FN, Kuiper RP.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39232206"},{"title01":"Leukaemia, lymphoma, and multiple myeloma mortality after low-level exposure to ionising radiation in nuclear workers (INWORKS): updated findings from an international cohort study","title02":"Leukaemia, lymphoma, and multiple myeloma mortality after low-level exposure to ionising radiation in nuclear workers (INWORKS): updated findings from an international cohort study","journal":"Lancet Haematol","issue":"2024 Aug 30:S2352-3026(24)00240-0. doi: 10.1016\/S2352-3026(24)00240-0. Online ahead of print.","author":"Leuraud K, Laurier D, Gillies M, Haylock R, Kelly-Reif K, Bertke S, Daniels RD, Thierry-Chef I, Moissonnier M, Kesminiene A, Schubauer-Berigan MK, Richardson DB.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39222647"},{"title01":"Endpoint Surrogacy in First-Line Chronic Lymphocytic Leukemia","title02":"Endpoint Surrogacy in First-Line Chronic Lymphocytic Leukemia","journal":"J Clin Oncol","issue":"2024 Aug 23:JCO2401192. doi: 10.1200\/JCO.24.01192. Online ahead of print.","author":"Simon F, Ligtvoet R, Robrecht S, Cramer P, Kutsch N, F\u00fcrstenau M, Goede V, von Tresckow J, Langerbeins P, Fink AM, Huber H, Tausch E, Schneider C, Wendtner CM, Ritgen M, Dreyling M, M\u00fcller L, Jacobasch L, Heinz WJ, Vehling-Kaiser U, Sivcheva L, B\u00f6ttcher S, Dreger P, Illmer T, Gregor M, Staber PB, Stilgenbauer S, Niemann CU, Kater AP, Fischer K, Eichhorst B, Hallek M, Al-Sawaf O.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39213466"},{"title01":"Risk Stratification in Older Intensively Treated Patients With AML","title02":"Risk Stratification in Older Intensively Treated Patients With AML","journal":"J Clin Oncol","issue":"2024 Sep 4:JCO2302631. doi: 10.1200\/JCO.23.02631. Online ahead of print.","author":"Versluis J, Metzner M, Wang A, Gradowska P, Thomas A, Jakobsen NA, Kennedy A, Moore R, Boertjes E, Vonk CM, Kavelaars FG, Rijken M, Gilkes A, Schwab C, Beverloo HB, Manz M, Visser O, Van Elssen CHMJ, de Weerdt O, Tick LW, Biemond BJ, Vekemans MC, Freeman SD, Harrison CJ, Cook JA, Dennis M, Knapper S, Thomas I, Craddock C, Ossenkoppele GJ, L\u00f6wenberg B, Russell N, Valk PJM, Vyas P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39231389"},{"title01":"The real world of acute lymphoblastic leukemia","title02":"The real world of acute lymphoblastic leukemia","journal":"Haematologica","issue":"2024 Sep 5. doi: 10.3324\/haematol.2024.286346. Online ahead of print.","author":"Litzow MR.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39234859"},{"title01":"Prognostic stratification in venetoclax-based acute myeloid leukemia treatments: the molecular prognostic risk signature tested in a real-world setting","title02":"Prognostic stratification in venetoclax-based acute myeloid leukemia treatments: the molecular prognostic risk signature tested in a real-world setting","journal":"Haematologica","issue":"2024 Sep 5. doi: 10.3324\/haematol.2024.285934. Online ahead of print.","author":"Ciolli G, Piccini M, Mannelli F, Gianfaldoni G, Scappini B, Fasano L, Crupi F, Quinti E, Pasquini A, Caroprese J, Rotunno G, Pancani F, Signori L, Maccari C, Vanderwert FI, Guglielmelli P, Vannucchi AM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39234864"},{"title01":"Blinatumomab is associated with better post-transplant outcome than chemotherapy in children with high-risk first-relapse B-cell acute lymphoblastic leukemia irrespective of the conditioning regimen","title02":"Blinatumomab is associated with better post-transplant outcome than chemotherapy in children with high-risk first-relapse B-cell acute lymphoblastic leukemia irrespective of the conditioning regimen","journal":"Haematologica","issue":"2024 Sep 5. doi: 10.3324\/haematol.2024.285837. Online ahead of print.","author":"Peters C, Bruno A, Rizzari C, Brescianini A, Von Stackelberg A, Linderkamp C, Zeng Y, Zugmaier G, Locatelli F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39234873"},{"title01":"LIPA-frogging blast phase chronic myeloid leukemia: hopping over resistance with lysosomal targeting","title02":"LIPA-frogging blast phase chronic myeloid leukemia: hopping over resistance with lysosomal targeting","journal":"Haematologica","issue":"2024 Aug 22. doi: 10.3324\/haematol.2024.286140. Online ahead of print.","author":"Quijada-\u00c1lamo M, Freed G, Wagenblast E.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39219462"},{"title01":"Utilization of allogeneic hematopoietic stem cell transplantation among patients with newly diagnosed acute myeloid leukemia in California: a population-based linked dataset study","title02":"Utilization of allogeneic hematopoietic stem cell transplantation among patients with newly diagnosed acute myeloid leukemia in California: a population-based linked dataset study","journal":"Haematologica","issue":"2024 Aug 29. doi: 10.3324\/haematol.2024.285648. Online ahead of print.","author":"Meyer CL, Keegan THM, Brunson A, Auletta JJ, Morton LM, Wun T, Schonfeld SJ, Valcarcel B, Abrah\u00e3o R, Yusuf RA, Muffly L.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39219504"},{"title01":"Hybrid allogeneic bone marrow transplant rescue approach after acute myelogenous leukaemia relapse in a high-risk patient","title02":"Hybrid allogeneic bone marrow transplant rescue approach after acute myelogenous leukaemia relapse in a high-risk patient","journal":"Br J Haematol","issue":"2024 Sep 5. doi: 10.1111\/bjh.19749. Online ahead of print.","author":"Villar-Prados A, Kennedy VE, Meyer EH.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39238111"},{"title01":"Backtracking childhood leukaemia to birth: A battle of addition","title02":"Backtracking childhood leukaemia to birth: A battle of addition","journal":"Br J Haematol","issue":"2024 Sep 5. doi: 10.1111\/bjh.19747. Online ahead of print.","author":"Spector LG, de Smith AJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39238151"},{"title01":"Paediatric acute lymphoblastic leukaemia-associated haemophagocytic lymphohistiocytosis develops during prednisolone prephase","title02":"Paediatric acute lymphoblastic leukaemia-associated haemophagocytic lymphohistiocytosis develops during prednisolone prephase","journal":"Br J Haematol","issue":"2024 Sep 9. doi: 10.1111\/bjh.19755. Online ahead of print.","author":"Tanabe S, Furui Y, Saito S, Okura E, Ide Y, Takezawa Y, Maruyama Y, Sakamoto K, Hirabayashi K, Tanaka M, Yanagisawa R, Nakazawa Y.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39248176"},{"title01":"Understanding splenic B-cell lymphoma\/leukaemia with prominent nucleoli: Diagnosis, underpinnings for disease classification and future directions","title02":"Understanding splenic B-cell lymphoma\/leukaemia with prominent nucleoli: Diagnosis, underpinnings for disease classification and future directions","journal":"Br J Haematol","issue":"2024 Sep 10. doi: 10.1111\/bjh.19754. Online ahead of print.","author":"Naresh KN.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39253895"},{"title01":"Telomere length and DNA methylation epitype both provide independent prognostic information in CLL patients; data from the UK CLL4, ARCTIC and ADMIRE clinical trials","title02":"Telomere length and DNA methylation epitype both provide independent prognostic information in CLL patients; data from the UK CLL4, ARCTIC and ADMIRE clinical trials","journal":"Br J Haematol","issue":"2024 Sep 10. doi: 10.1111\/bjh.19765. Online ahead of print.","author":"Carr L, Norris K, Parker H, Nilsson-Takeuchi A, Bryant D, Amarasinghe H, Kadalayil L, Else M, Pettitt A, Hillmen P, Schuh A, Walewska R, Baird DM, Oscier DG, Oakes CC, Gibson J, Pepper C, Strefford JC.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39253978"},{"title01":"Outcomes of Bruton tyrosine kinase inhibitors for chronic lymphocytic leukaemia in US veterans with severe renal dysfunction","title02":"Outcomes of Bruton tyrosine kinase inhibitors for chronic lymphocytic leukaemia in US veterans with severe renal dysfunction","journal":"Br J Haematol","issue":"2024 Aug 29. doi: 10.1111\/bjh.19737. Online ahead of print.","author":"Lin C, Anderson CE, Scobie MR, Rodgers TD, Kelley MJ, Friedman DR.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39209771"},{"title01":"Pericardial events associated with ibrutinib-based therapies for chronic lymphocytic leukaemia in two landmark trials","title02":"Pericardial events associated with ibrutinib-based therapies for chronic lymphocytic leukaemia in two landmark trials","journal":"Br J Haematol","issue":"2024 Sep 1. doi: 10.1111\/bjh.19710. Online ahead of print.","author":"Fakhri B, Wang V, Perez-Burbano G, Wall A, Mandrekar S, Parikh SA, Woyach J, Shanafelt T.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39219152"},{"title01":"TCR targeting hematopoiesis to cure leukemia","title02":"TCR targeting hematopoiesis to cure leukemia","journal":"Blood","issue":"2024 Sep 5;144(10):1031-1033.","author":"Falkenburg JHF, Heemskerk MHM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39235801"},{"title01":"TP53-Mutated Acute Myeloid Leukemia: How Can We Improve Outcomes?","title02":"TP53-Mutated Acute Myeloid Leukemia: How Can We Improve Outcomes?","journal":"Blood","issue":"2024 Sep 5:blood.2024024245. doi: 10.1182\/blood.2024024245. Online ahead of print.","author":"Sallman DA, Stahl M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39236289"},{"title01":"Incorporation of immunotherapy into frontline treatment for adults with B-cell precursor acute lymphoblastic leukemia","title02":"Incorporation of immunotherapy into frontline treatment for adults with B-cell precursor acute lymphoblastic leukemia","journal":"Blood","issue":"2024 Sep 5:blood.2023022921. doi: 10.1182\/blood.2023022921. Online ahead of print.","author":"Badar T, Luger SM, Litzow MR.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39236292"},{"title01":"Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in Adults over 70 years old","title02":"Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in Adults over 70 years old","journal":"Blood","issue":"2024 Sep 6:blood.2024024247. doi: 10.1182\/blood.2024024247. Online ahead of print.","author":"Walter RB, Potter V, Craddock C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39241195"},{"title01":"Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy","title02":"Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy","journal":"N Engl J Med","issue":"2024 Sep 5;391(9):869-870.","author":"Godfrey J, Querfeld C, Song J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39231354"},{"title01":"Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy. Reply","title02":"Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy. Reply","journal":"N Engl J Med","issue":"2024 Sep 5;391(9):870-871.","author":"Hamilton MP, Miklos DB, Alizadeh AA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39231355"},{"title01":"Leukaemia, lymphoma, and multiple myeloma mortality after low-level exposure to ionising radiation in nuclear workers (INWORKS): updated findings from an international cohort study","title02":"Leukaemia, lymphoma, and multiple myeloma mortality after low-level exposure to ionising radiation in nuclear workers (INWORKS): updated findings from an international cohort study","journal":"Lancet Haematol","issue":"2024 Aug 30:S2352-3026(24)00240-0. doi: 10.1016\/S2352-3026(24)00240-0. Online ahead of print.","author":"Leuraud K, Laurier D, Gillies M, Haylock R, Kelly-Reif K, Bertke S, Daniels RD, Thierry-Chef I, Moissonnier M, Kesminiene A, Schubauer-Berigan MK, Richardson DB.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39222647"},{"title01":"Nodular lymphocyte-predominant Hodgkin lymphoma: advances in disease biology, risk stratification, and treatment","title02":"Nodular lymphocyte-predominant Hodgkin lymphoma: advances in disease biology, risk stratification, and treatment","journal":"Haematologica","issue":"2024 Sep 5. doi: 10.3324\/haematol.2024.285903. Online ahead of print.","author":"Salvaris RT, Allanson BM, Collins G, Cheah C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39234861"},{"title01":"Safety and efficacy of acalabrutinib plus bendamustine and rituximab in patients with treatment-naive or relapsed \/ refractory mantle cell lymphoma: phase Ib trial","title02":"Safety and efficacy of acalabrutinib plus bendamustine and rituximab in patients with treatment-naive or relapsed \/ refractory mantle cell lymphoma: phase Ib trial","journal":"Haematologica","issue":"2024 Sep 5. doi: 10.3324\/haematol.2023.284896. Online ahead of print.","author":"Phillips T, Wang M, Robak T, Gallinson D, Stevens D, Patel K, Ramadan S, Wun CC, Jurczak W, Smith SD.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39234862"},{"title01":"Rituximab and lenalidomide for the treatment of relapsed or refractory indolent non-Hodgkin lymphoma: real-life experience","title02":"Rituximab and lenalidomide for the treatment of relapsed or refractory indolent non-Hodgkin lymphoma: real-life experience","journal":"Haematologica","issue":"2024 Sep 5. doi: 10.3324\/haematol.2024.285600. Online ahead of print.","author":"Cassanello G, Drill E, Rivas-Delgado A, Okwali M, Isgor I, Caron PC, Epstein-Peterson Z, Ghione P, Hamlin P, Lue J, Horwitz SM, Intlekofer AM, Johnson W, Kumar A, Moskowitz A, Noy A, Owens C, Palomba LM, Torka P, Galera P, Zelenetz AD, Salles G, Falchi L.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39234863"},{"title01":"Loncastuximab tesirine in Chinese patients with relapsed or refractory diffuse large B-cell lymphoma: a multicenter, open-label, single-arm, phase II trial","title02":"Loncastuximab tesirine in Chinese patients with relapsed or refractory diffuse large B-cell lymphoma: a multicenter, open-label, single-arm, phase II trial","journal":"Haematologica","issue":"2024 Sep 5. doi: 10.3324\/haematol.2024.284973. Online ahead of print.","author":"Lin N, Sun X, Zhou H, Zou L, Zhou K, Liu L, Yang H, Hu K, Cai Q, Liu Y, Jin J, Zhang L, Li W, Guo Y, Yang W, Luo F, Wang Z, Zhu R, Yang L, Song D, Song Y, Zhu J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39234866"},{"title01":"Outcomes of patients with primary central nervous system lymphoma following CD19-targeted chimeric antigen receptor T-cell therapy","title02":"Outcomes of patients with primary central nervous system lymphoma following CD19-targeted chimeric antigen receptor T-cell therapy","journal":"Haematologica","issue":"2024 Sep 5. doi: 10.3324\/haematol.2024.285613. Online ahead of print.","author":"Mercadal S, Ahn KW, Allbee-Johnson M, Ganguly S, Geethakumari PR, Hong S, Malone A, Murthy H, Pawarode A, Sica AR, Solh M, Ustun C, Shadman M, Sauter CS, Hamadani M, Herrera AF, Lee CJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39234871"},{"title01":"T-cell receptor architecture and clonal tiding provide insight into the transformation trajectory of peripheral T-cell lymphomas","title02":"T-cell receptor architecture and clonal tiding provide insight into the transformation trajectory of peripheral T-cell lymphomas","journal":"Haematologica","issue":"2024 Aug 29. doi: 10.3324\/haematol.2024.285395. Online ahead of print.","author":"Willscher E, Schulthei\u00df C, Paschold L, Lea Sch\u00fcmann F, Schmidt-Barbo P, Thiele B, Bauer M, Wickenhauser C, Weber T, Binder M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39219501"},{"title01":"Understanding splenic B-cell lymphoma\/leukaemia with prominent nucleoli: Diagnosis, underpinnings for disease classification and future directions","title02":"Understanding splenic B-cell lymphoma\/leukaemia with prominent nucleoli: Diagnosis, underpinnings for disease classification and future directions","journal":"Br J Haematol","issue":"2024 Sep 10. doi: 10.1111\/bjh.19754. Online ahead of print.","author":"Naresh KN.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39253895"},{"title01":"Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in Adults over 70 years old","title02":"Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in Adults over 70 years old","journal":"Blood","issue":"2024 Sep 6:blood.2024024247. doi: 10.1182\/blood.2024024247. Online ahead of print.","author":"Walter RB, Potter V, Craddock C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39241195"},{"title01":"CML 25 Years Later – Poised for Another Breakthrough?","title02":"CML 25 Years Later – Poised for Another Breakthrough?","journal":"N Engl J Med","issue":"2024 Sep 12;391(10):955-957.","author":"Abruzzese E.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39259899"},{"title01":"WT1 together with RUNX1::RUNX1T1 targets DUSP6 to dampen ERK activity in acute myeloid leukaemia","title02":"WT1 together with RUNX1::RUNX1T1 targets DUSP6<\/i> to dampen ERK activity in acute myeloid leukaemia","journal":"Br J Haematol","issue":"2024 Aug 27. doi: 10.1111\/bjh.19721. Online ahead of print.","author":"Xu N, Dao FT, Shi ZY, Sun K, Qin YZ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39191510"},{"title01":"CREBBP histone acetyltransferase domain mutations predict response to mTOR inhibition in relapsed\/refractory follicular lymphoma","title02":"CREBBP<\/i> histone acetyltransferase domain mutations predict response to mTOR inhibition in relapsed\/refractory follicular lymphoma","journal":"Br J Haematol","issue":"2024 Aug 26. doi: 10.1111\/bjh.19671. Online ahead of print.","author":"Kumar EA, Korfi K, Bewicke-Copley F, Close K, Heward J, Witzig T, Leukam M, Ansell S, Scott J, Clear A, Efeyan A, Green M, Siebert R, Peck B, Calaminici M, Wang J, Smith S, Novak A, Fitzgibbon J, Okosun J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39188028"},{"title01":"An unbiased lncRNAs dropout CRISPR-Cas9 screen reveals RP11-350G8.5 as a novel therapeutic target for Multiple Myeloma","title02":"An unbiased lncRNAs dropout CRISPR-Cas9 screen reveals RP11-350G8.5 as a novel therapeutic target for Multiple Myeloma","journal":"Blood","issue":"2024 Aug 16:blood.2023021991. doi: 10.1182\/blood.2023021991. Online ahead of print.","author":"Grillone K, Ascrizzi S, Cremaschi P, Amato J Professor, Poler\u00e0 N, Croci O, Rocca R, Riillo C, Conforti F, Graziano R, Brancaccio D, Caracciolo D, Alcaro S, Pagano B, Randazzo A, Tagliaferri P, Iorio F, Tassone P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39158066"},{"title01":"New insights into pregnancy after stem-cell transplantation","title02":"New insights into pregnancy after stem-cell transplantation","journal":"Lancet Haematol","issue":"2024 Sep;11(9):e629.","author":"The Lancet Haematology.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39181612"},{"title01":"Second allogeneic stem-cell transplantation or donor lymphocyte infusion in patients who relapse after transplantation?","title02":"Second allogeneic stem-cell transplantation or donor lymphocyte infusion in patients who relapse after transplantation?","journal":"Lancet Haematol","issue":"2024 Sep;11(9):e642-e643.","author":"Robin M, Scheid C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39181614"},{"title01":"Extending the boundaries of organ preservation: hope for heart transplantation","title02":"Extending the boundaries of organ preservation: hope for heart transplantation","journal":"Lancet","issue":"2024 Aug 17;404(10453):631-633.","author":"Kittleson MM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39153800"},{"title01":"Hypothermic oxygenated perfusion of the donor heart in heart transplantation: the short-term outcome from a randomised, controlled, open-label, multicentre clinical trial","title02":"Hypothermic oxygenated perfusion of the donor heart in heart transplantation: the short-term outcome from a randomised, controlled, open-label, multicentre clinical trial","journal":"Lancet","issue":"2024 Aug 17;404(10453):670-682.","author":"Rega F, Lebreton G, Para M, Michel S, Schramm R, Begot E, Vandendriessche K, Kamla C, Gerosa G, Berman M, Boeken U, Clark S, Ranasinghe A, Ius F, Forteza A, Pivodic A, Hennig F, Guenther S, Zuckermann A, Knosalla C, Dellgren G, Wallinder A; NIHP2019 investigators.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39153817"},{"title01":"A Multicenter Phase II Trial of Ruxolitinib for Treatment of Corticosteroid Refractory Sclerotic Chronic Graft-Versus-Host Disease","title02":"A Multicenter Phase II Trial of Ruxolitinib for Treatment of Corticosteroid Refractory Sclerotic Chronic Graft-Versus-Host Disease","journal":"J Clin Oncol","issue":"2024 Aug 16:JCO2400205. doi: 10.1200\/JCO.24.00205. Online ahead of print.","author":"Bhatt VR, Shostrom VK, Choe HK, Hamilton BK, Gundabolu K, Maness LJ, Kumar V, Mahato RI, Smith LM, Nishihori T, Lee SJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39151112"},{"title01":"How Important Is Unrelated Donor Human Leukocyte Antigen Disparity in the Post-Transplant Cyclophosphamide Era?","title02":"How Important Is Unrelated Donor Human Leukocyte Antigen Disparity in the Post-Transplant Cyclophosphamide Era?","journal":"J Clin Oncol","issue":"2024 Aug 21:JCO2401303. doi: 10.1200\/JCO-24-01303. Online ahead of print.","author":"Chakraverty R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39167734"},{"title01":"Human Leukocyte Antigen Mismatching and Survival in Contemporary Hematopoietic Cell Transplantation for Hematologic Malignancies","title02":"Human Leukocyte Antigen Mismatching and Survival in Contemporary Hematopoietic Cell Transplantation for Hematologic Malignancies","journal":"J Clin Oncol","issue":"2024 Aug 21:JCO2400582. doi: 10.1200\/JCO.24.00582. Online ahead of print.","author":"Arrieta-Bola\u00f1os E, Bonneville EF, Crivello P, Robin M, Gedde-Dahl T, Salmenniemi U, Kr\u00f6ger N, Yakoub-Agha I, Crawley C, Choi G, Broers AEC, Forcade E, Carre M, Poir\u00e9 X, Huynh A, Lenhoff S, Ciceri F, Tholouli E, Schroeder T, Deconinck E, Carlson K, de Wreede LC, Hoogenboom JD, Malard F, Ruggeri A, Fleischhauer K; Cellular Therapy and Immunobiology Working Party of the EBMT.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39167735"},{"title01":"Long-term outcome after allogeneic stem cell transplantation for GATA2 deficiency: An analysis of 67 adults and children from France and Belgium","title02":"Long-term outcome after allogeneic stem cell transplantation for GATA2 deficiency: An analysis of 67 adults and children from France and Belgium","journal":"Br J Haematol","issue":"2024 Aug 19. doi: 10.1111\/bjh.19691. Online ahead of print.","author":"Sicre de Fontbrune F, Chevillon F, Fahd M, Desseaux K, Poir\u00e9 X, Forcade E, Sterin A, Neven B, Gandemer V, Thepot S, Garnier A, Lioure B, Marcais A, Nguyen-Quoc S, Tavitian S, Vincent L, Donadieu J, Resche Riggon M, Chevret S, Pasquet M, Peffault de Latour R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39159950"},{"title01":"GVHD: bile duct stem cells under attack","title02":"GVHD: bile duct stem cells under attack","journal":"Blood","issue":"2024 Aug 22;144(8):805-807.","author":"Apostolova P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39172441"},{"title01":"Lightening the load for paediatric ITP: The importance of health-related quality of life","title02":"Lightening the load for paediatric ITP: The importance of health-related quality of life","journal":"Br J Haematol","issue":"2024 Aug 27. doi: 10.1111\/bjh.19719. Online ahead of print.","author":"Neunert CE, Lambert MP.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39191677"},{"title01":"Activation of the HMGB1-TLR4 pathway impacts the functionality of bone marrow mesenchymal stem cells and disrupts macrophage polarization in immune thrombocytopenia","title02":"Activation of the HMGB1-TLR4 pathway impacts the functionality of bone marrow mesenchymal stem cells and disrupts macrophage polarization in immune thrombocytopenia","journal":"Br J Haematol","issue":"2024 Aug 21. doi: 10.1111\/bjh.19709. Online ahead of print.","author":"Liang Z, Zhang G, Gan G, Naren D, Liu X, Liu H, Nie D, Ma L.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39169447"},{"title01":"YAP1 regulates thrombopoiesis by binding to MYH9 in immune thrombocytopenia","title02":"YAP1 regulates thrombopoiesis by binding to MYH9 in immune thrombocytopenia","journal":"Blood","issue":"2024 Aug 27:blood.2023023601. doi: 10.1182\/blood.2023023601. Online ahead of print.","author":"Hu S, Liu Y, Zhang X, Wang X, Li Y, Chu M, Yin J, Fang Y, Ruan C, Zhu L, Wu D, Xu Y.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39190466"},{"title01":"Evolution of T-cell fitness through AML progression: enhanced bispecific T-cell engager-mediated function of bone marrow T cells at remission compared to initial diagnosis and relapse","title02":"Evolution of T-cell fitness through AML progression: enhanced bispecific T-cell engager-mediated function of bone marrow T cells at remission compared to initial diagnosis and relapse","journal":"Leukemia","issue":"2024 Aug 22. doi: 10.1038\/s41375-024-02387-4. Online ahead of print.","author":"Kazerani M, Marcinek A, Philipp N, Brauchle B, Taylor JJ, Moreno HD, Terrasi A, Tast B, Rohrbacher L, Wang Y, Warm M, Emhardt AJ, Magno G, Spiekermann K, Herold T, Straub T, Theurich S, Schotta G, Kischel R, B\u00fccklein VL, Subklewe M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39174782"},{"title01":"STING is crucial for the survival of RUNX1::RUNX1T1 leukemia cells","title02":"STING is crucial for the survival of RUNX1::RUNX1T1 leukemia cells","journal":"Leukemia","issue":"2024 Aug 23. doi: 10.1038\/s41375-024-02383-8. Online ahead of print.","author":"Sun Y, Wu Y, Pang G, Huang J, Sheng M, Xie J, Chen P, Wang Y, Yin D, Zhao G, Bohlander SK, Huang J, Xu GL, Gao H, Zhou D, Shi Y.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39179670"},{"title01":"Menin inhibitors in pediatric acute leukemia: a comprehensive review and recommendations to accelerate progress in collaboration with adult leukemia and the international community","title02":"Menin inhibitors in pediatric acute leukemia: a comprehensive review and recommendations to accelerate progress in collaboration with adult leukemia and the international community","journal":"Leukemia","issue":"2024 Aug 23. doi: 10.1038\/s41375-024-02368-7. Online ahead of print.","author":"Cuglievan B, Kantarjian H, Rubnitz JE, Cooper TM, Zwaan CM, Pollard JA, DiNardo CD, Kadia TM, Guest E, Short NJ, McCall D, Daver N, Nunez C, Haddad FG, Garcia M, Bhalla KN, Maiti A, Catueno S, Fiskus W, Carter BZ, Gibson A, Roth M, Khazal S, Tewari P, Abbas HA, Bourgeois W, Andreeff M, Shukla NN, Truong DD, Connors J, Ludwig JA, Stutterheim J, Salzer E, Juul-Dam KL, Sasaki K, Mahadeo KM, Tasian SK, Borthakur G, Dickson S, Jain N, Jabbour E, Meshinchi S, Garcia-Manero G, Ravandi F, Stein EM, Kolb EA, Issa GC.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39179671"},{"title01":"A multidimensional analysis reveals distinct immune phenotypes and the composition of immune aggregates in pediatric acute myeloid leukemia","title02":"A multidimensional analysis reveals distinct immune phenotypes and the composition of immune aggregates in pediatric acute myeloid leukemia","journal":"Leukemia","issue":"2024 Aug 26. doi: 10.1038\/s41375-024-02381-w. Online ahead of print.","author":"Koedijk JB, van der Werf I, Penter L, Vermeulen MA, Barneh F, Perzolli A, Meesters-Ensing JI, Metselaar DS, Margaritis T, Fiocco M, de Groot-Kruseman HA, Moeniralam R, Bang Christensen K, Porter B, Pfaff K, Garcia JS, Rodig SJ, Wu CJ, Hasle H, Nierkens S, Belderbos ME, Zwaan CM, Heidenreich O.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39187578"},{"title01":"Stearoyl-CoA desaturase inhibition is toxic to acute myeloid leukemia displaying high levels of the de novo fatty acid biosynthesis and desaturation","title02":"Stearoyl-CoA desaturase inhibition is toxic to acute myeloid leukemia displaying high levels of the de novo fatty acid biosynthesis and desaturation","journal":"Leukemia","issue":"2024 Aug 26. doi: 10.1038\/s41375-024-02390-9. Online ahead of print.","author":"Dembitz V, Lawson H, Burt R, Natani S, Philippe C, James SC, Atkinson S, Durko J, Wang LM, Campos J, Magee AMS, Woodley K, Austin MJ, Rio-Machin A, Casado P, Bewicke-Copley F, Rodriguez Blanco G, Pereira-Martins D, Oudejans L, Boet E, von Kriegsheim A, Schwaller J, Finch AJ, Patel B, Sarry JE, Tamburini J, Schuringa JJ, Hazlehurst L, Copland Iii JA, Yuneva M, Peck B, Cutillas P, Fitzgibbon J, Rouault-Pierre K, Kranc K, Gallipoli P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39187579"},{"title01":"Genetic hallmarks and clinical implications of chromothripsis in childhood T-cell acute lymphoblastic leukemia","title02":"Genetic hallmarks and clinical implications of chromothripsis in childhood T-cell acute lymphoblastic leukemia","journal":"Leukemia","issue":"2024 Aug 27. doi: 10.1038\/s41375-024-02370-z. Online ahead of print.","author":"Pastorczak A, Urbanska Z, Styka B, Miarka-Walczyk K, Sedek L, Wypyszczak K, Wakulinska A, Nowicka Z, Szczepa\u0144ski T, Sta\u0144czak M, Fendler W, Kowalczyk J, M\u0142ynarski W, Lejman M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39192035"},{"title01":"Third-generation anti-CD19 CAR T cells for relapsed\/refractory chronic lymphocytic leukemia: a phase 1\/2 study","title02":"Third-generation anti-CD19 CAR T cells for relapsed\/refractory chronic lymphocytic leukemia: a phase 1\/2 study","journal":"Leukemia","issue":"2024 Aug 27. doi: 10.1038\/s41375-024-02392-7. Online ahead of print.","author":"Derigs P, Schubert ML, Dreger P, Schmitt A, Yousefian S, Haas S, R\u00f6themeier C, Neuber B, H\u00fcckelhoven-Krauss A, Br\u00fcggemann M, Bernhard H, Kobbe G, Lindemann A, Rummel M, Michels B, Korell F, Ho AD, M\u00fcller-Tidow C, Schmitt M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39192036"},{"title01":"Efficacy and safety of bosutinib in previously treated patients with chronic myeloid leukemia: final results from the BYOND trial","title02":"Efficacy and safety of bosutinib in previously treated patients with chronic myeloid leukemia: final results from the BYOND trial","journal":"Leukemia","issue":"2024 Aug 20. doi: 10.1038\/s41375-024-02372-x. Online ahead of print.","author":"Gambacorti-Passerini C, Br\u00fcmmendorf TH, Abruzzese E, Kelly KR, Oehler VG, Garc\u00eda-Guti\u00e9rrez V, Hjorth-Hansen H, Ernst T, Leip E, Purcell S, Luscan G, Viqueira A, Giles FJ, Hochhaus A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39164407"},{"title01":"Identification of leukemia stem cell subsets with distinct transcriptional, epigenetic and functional properties","title02":"Identification of leukemia stem cell subsets with distinct transcriptional, epigenetic and functional properties","journal":"Leukemia","issue":"2024 Aug 21. doi: 10.1038\/s41375-024-02358-9. Online ahead of print.","author":"Boutzen H, Murison A, Oriecuia A, Bansal S, Arlidge C, Wang JCY, Lupien M, Kaufmann KB, Dick JE.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39169113"},{"title01":"Optimal prognostic threshold for measurable residual disease positivity by multiparameter flow cytometry in acute myeloid leukemia (AML)","title02":"Optimal prognostic threshold for measurable residual disease positivity by multiparameter flow cytometry in acute myeloid leukemia (AML)","journal":"Leukemia","issue":"2024 Aug 21. doi: 10.1038\/s41375-024-02378-5. Online ahead of print.","author":"Rodr\u00edguez-Arbol\u00ed E, Othus M, Freeman SD, Buccisano F, Ngai LL, Thomas I, Palmieri R, Cloos J, Johnson S, Meddi E, Russell NH, Venditti A, Gradowska P, Ossenkoppele GJ, L\u00f6wenberg B, Walter RB.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39169114"},{"title01":"Single-cell proteo-transcriptomic profiling reveals altered characteristics of stem and progenitor cells in patients receiving cytoreductive hydroxyurea in early-phase chronic myeloid leukemia","title02":"Single-cell proteo-transcriptomic profiling reveals altered characteristics of stem and progenitor cells in patients receiving cytoreductive hydroxyurea in early-phase chronic myeloid leukemia","journal":"Haematologica","issue":"2024 Aug 15:0. doi: 10.3324\/haematol.2024.285071. Online ahead of print.","author":"Komic H, Nilsson MS, Wennstr\u00f6m L, Bandaru TS, Jaako P, Hellstrand K, Thor\u00e9n FB, Martner A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39157872"},{"title01":"Cd39 and P2rx7-Wnt signaling enhance blast pathogenicity in an experimental model of acute myeloid leukemia","title02":"Cd39 and P2rx7-Wnt signaling enhance blast pathogenicity in an experimental model of acute myeloid leukemia","journal":"Haematologica","issue":"2024 Aug 15:0. doi: 10.3324\/haematol.2024.285547. Online ahead of print.","author":"Feng L, Zhang H, Mao C, De Andrade Mello P, Stroopinsky D, Csizmadia E, Zhou J, Avigan D, Yu J, Gao W, Robson SC.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39157874"},{"title01":"Outcome of 421 adult patients with Philadelphia-negative acute lymphoblastic leukemia treated under an intensive program inspired by the GIMEMA LAL1913 clinical trial: a Campus ALL study","title02":"Outcome of 421 adult patients with Philadelphia-negative acute lymphoblastic leukemia treated under an intensive program inspired by the GIMEMA LAL1913 clinical trial: a Campus ALL study","journal":"Haematologica","issue":"2024 Aug 15:0. doi: 10.3324\/haematol.2024.285638. Online ahead of print.","author":"Lazzarotto D, Cerrano M, Papayannidis C, Chiaretti S, Mosna F, Fracchiolla N, Zappasodi P, Imbergamo S, Del Principe MI, Lunghi M, Lussana F, Piccini M, Fumagalli M, Dargenio M, Salutari P, Forghieri F, Da Molin TG, Bonifacio M, Olivi M, Giglio F, Trappolini S, Leoncin M, Mule A, Delia M, Pasciolla C, Grimaldi F, Cambo B, Santoro L, Guolo F, Minetto P, Defina M, Chiusolo P, Fanin M, Mauro E, Aprile L, Mazzone C, Trastulli F, Ciccone M, De Gobbi M, Cignetti A, De Bellis E, Mancini V, Piciocchi A, Vignetti M, Marsili G, Starza ID, Fanin R, Luppi M, Ferrara F, Pizzolo G, Bassan R, Foa R, Candoni A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39157875"},{"title01":"Clinical relevance of NFYA splice variants in patients with acute myeloid leukaemia undergoing intensive chemotherapy","title02":"Clinical relevance of NFYA splice variants in patients with acute myeloid leukaemia undergoing intensive chemotherapy","journal":"Br J Haematol","issue":"2024 Aug 28. doi: 10.1111\/bjh.19733. Online ahead of print.","author":"Yang YT, Yao CY, Kao CJ, Chiu PJ, Lin ME, Hou HA, Lin CC, Chou WC, Tien HF.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39192759"},{"title01":"AML, myelodysplasia related, with STAG2 and SRSF2 comutations with myelocyte arrest","title02":"AML, myelodysplasia related, with STAG2 and SRSF2 comutations with myelocyte arrest","journal":"Blood","issue":"2024 Aug 22;144(8):918.","author":"Xu Z, Padmore R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39172440"},{"title01":"Hijacking T helper cells for AML progression","title02":"Hijacking T helper cells for AML progression","journal":"Blood","issue":"2024 Aug 22;144(8):804-805.","author":"Ingelfinger F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39172443"},{"title01":"Childhood leukemia prevention within reach","title02":"Childhood leukemia prevention within reach","journal":"Blood","issue":"2024 Aug 22;144(8):799-800.","author":"Cobaleda C, S\u00e1nchez-Garc\u00eda I.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39172445"},{"title01":"Antimetabolite Dose Intensity and Adverse Outcomes in Children with Acute Lymphoblastic Leukemia: A COG-AALL03N1 Report","title02":"Antimetabolite Dose Intensity and Adverse Outcomes in Children with Acute Lymphoblastic Leukemia: A COG-AALL03N1 Report","journal":"Blood","issue":"2024 Aug 27:blood.2024024455. doi: 10.1182\/blood.2024024455. Online ahead of print.","author":"Wadhwa A, Chen Y, Hageman L, Angiolillo A, Dickens D, Neglia JP, Ravindranath Y, Termuhlen A, Wong FL, Landier W, Bhatia S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39190431"},{"title01":"NPM1-mutated AML: how many diseases?","title02":"NPM1-mutated AML: how many diseases?","journal":"Blood","issue":"2024 Aug 15;144(7):681-683.","author":"Itzykson R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39145943"},{"title01":"Immature erythroblasts in pleural effusion: an initial presentation of acute erythroid leukemia in a patient with a history of MDS","title02":"Immature erythroblasts in pleural effusion: an initial presentation of acute erythroid leukemia in a patient with a history of MDS","journal":"Blood","issue":"2024 Aug 15;144(7):794.","author":"Hu Z, Ok CY.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39145944"},{"title01":"Epigenetic Regulation of Non-canonical Menin Targets Modulates Menin Inhibitor Response in Acute Myeloid Leukemia","title02":"Epigenetic Regulation of Non-canonical Menin Targets Modulates Menin Inhibitor Response in Acute Myeloid Leukemia","journal":"Blood","issue":"2024 Aug 16:blood.2023023644. doi: 10.1182\/blood.2023023644. Online ahead of print.","author":"Zhou X, Zhang L, Aryal S, Veasey V, Tajik A, Restelli C, Moreira S, Zhang P, Zhang Y, Hope K, Zhou Y, Cheng C, Bhatia R, Lu R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39158067"},{"title01":"Daratumumab in Pediatric Relapsed\/Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma: DELPHINUS Study","title02":"Daratumumab in Pediatric Relapsed\/Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma: DELPHINUS Study","journal":"Blood","issue":"2024 Aug 16:blood.2024024493. doi: 10.1182\/blood.2024024493. Online ahead of print.","author":"Bhatla T, Hogan L MD, Teachey DT, Bautista F, Moppett JP, Velasco P, Micalizzi C, Rossig C, Shukla NN, Gilad G, Locatelli F, Baruchel A, Zwaan M, Bezler NS, Rubio-San-Sim\u00f3n A, Taussig D, Raetz EA, Mao ZJ, Wood B, Alvarez Arias D Dr, Krevvata M, Nnane I, Bandyopadhyay N, Lopez Solano L, Dennis RM, Carson R, Vora A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39158071"},{"title01":"Identification, risk factors, and clinical course of CNS relapse in DLBCL patients across 19 prospective phase 2 and 3 trials-a LYSA and GLA\/ DSHNHL collaboration","title02":"Identification, risk factors, and clinical course of CNS relapse in DLBCL patients across 19 prospective phase 2 and 3 trials-a LYSA and GLA\/ DSHNHL collaboration","journal":"Leukemia","issue":"2024 Aug 16. doi: 10.1038\/s41375-024-02371-y. Online ahead of print.","author":"Frontzek F, Renaud L, D\u00fchrsen U, Poeschel V, Bernard S, Chartier L, Ketterer N, R\u00e9cher C, Fitoussi O, Held G, Casasnovas O, Haioun C, Mounier N, Tilly H, Morschhauser F, Le Gouill S, Karsten IE, Duns G, Steidl C, Scott DW, Klapper W, Rosenwald A, Ott G, Molina T, Lenz G, Ziepert M, Altmann B, Thieblemont C, Schmitz N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39152324"},{"title01":"Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results","title02":"Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results","journal":"J Clin Oncol","issue":"2024 Aug 19:JCO2401373. doi: 10.1200\/JCO-24-01373. Online ahead of print.","author":"Martelli M, Ceriani L, Ciccone G, Ricardi U, Kriachok I, Botto B, Balzarotti M, Tucci A, Usai SV, Zilioli VR, Pennese E, Arcaini L, Dabrowska-Iwanicka A, Ferreri AJ, Merli F, Zhao W, Rigacci L, Cellini C, Hodgson D, Ionescu C, Minoia C, Lucchini E, Spina M, Foss\u00e5 A, Janikova A, Cwynarski K, Mikhaeel G, Jerkeman M, Di Rocco A, Stepanishyna Y, Vitolo U, Santoro A, Re A, Puccini B, Olivieri J, Petrucci L, Barrington SF, Malkowski B, Metser U, Versari A, Chauvie S, Walewski J, Trneny M, Cavalli F, Gospodarowicz M, Johnson PWM, Davies A, Zucca E; International Extranodal Lymphoma Study Group (IELSG).","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39159403"},{"title01":"A novel prognostic nomogram based on imaging and molecular parameters for newly diagnosed extranodal natural killer\/T-cell lymphoma patients","title02":"A novel prognostic nomogram based on imaging and molecular parameters for newly diagnosed extranodal natural killer\/T-cell lymphoma patients","journal":"Haematologica","issue":"2024 Aug 15:0. doi: 10.3324\/haematol.2024.285362. Online ahead of print.","author":"Huang D, Li F, Lin S, Xia J, Liu B, Li X, Ma N, Duan Y, Zeng Y, Zhou S, Tang S, Huang W, Rao L, Gao L, Li Q, Zhang X, Rao J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39157873"},{"title01":"Impact of the total lesion glycolysis (TLG) in predicting response of follicular lymphoma to rituximab","title02":"Impact of the total lesion glycolysis (TLG) in predicting response of follicular lymphoma to rituximab","journal":"Br J Haematol","issue":"2024 Aug 27. doi: 10.1111\/bjh.19724. Online ahead of print.","author":"Pignot PE, Bahri H, Malartre S, Morisset S, Lebras L, Guillermin Y, Nicolas E, Rey P, Belhabri A, Jauffret L, Fyot E, Thisse A, Bocquet A, Michallet AS.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39191676"},{"title01":"Ready, AIM, stop: ibrutinib plus venetoclax in MCL","title02":"Ready, AIM, stop: ibrutinib plus venetoclax in MCL","journal":"Blood","issue":"2024 Aug 22;144(8):800-802.","author":"Wallace DS, Barr PM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39172439"},{"title01":"Boosting CAR T cells against lymphomas","title02":"Boosting CAR T cells against lymphomas","journal":"Blood","issue":"2024 Aug 15;144(7):689-691.","author":"Pabst T, Bacher U.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39145947"},{"title01":"Daratumumab in Pediatric Relapsed\/Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma: DELPHINUS Study","title02":"Daratumumab in Pediatric Relapsed\/Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma: DELPHINUS Study","journal":"Blood","issue":"2024 Aug 16:blood.2024024493. doi: 10.1182\/blood.2024024493. Online ahead of print.","author":"Bhatla T, Hogan L MD, Teachey DT, Bautista F, Moppett JP, Velasco P, Micalizzi C, Rossig C, Shukla NN, Gilad G, Locatelli F, Baruchel A, Zwaan M, Bezler NS, Rubio-San-Sim\u00f3n A, Taussig D, Raetz EA, Mao ZJ, Wood B, Alvarez Arias D Dr, Krevvata M, Nnane I, Bandyopadhyay N, Lopez Solano L, Dennis RM, Carson R, Vora A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39158071"},{"title01":"A multi-center, phase Ib study of subcutaneous administration of isatuximab in combination with pomalidomide and dexamethasone in patients with relapsed\/refractory multiple myeloma","title02":"A multi-center, phase Ib study of subcutaneous administration of isatuximab in combination with pomalidomide and dexamethasone in patients with relapsed\/refractory multiple myeloma","journal":"Haematologica","issue":"2024 Aug 15:0. doi: 10.3324\/haematol.2023.284730. Online ahead of print.","author":"Quach H, Parmar G, Ocio EM, Prince HM, Oriol A, Crowther H, Tsukada N, Bories P, Madan S, Nathwani N, Sunami K, Semiond D, Yu D, Cordero P, Mac\u00e9 S, Suzan F, Moreau P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39157871"},{"title01":"Immune prognostic score predicts the risk of infection and survival outcomes in patients with relapsed multiple myeloma treated with bispecific antibodies","title02":"Immune prognostic score predicts the risk of infection and survival outcomes in patients with relapsed multiple myeloma treated with bispecific antibodies","journal":"Br J Haematol","issue":"2024 Aug 27. doi: 10.1111\/bjh.19700. Online ahead of print.","author":"Akhtar OS, Szabo A, Bhatlapenumarthi V, Forsberg M, Balev M, Patwari A, Cheruvalath H, Bhutani D, Thanendrarajan S, Dhakal B, Zangari M, Patel T, Shrestha A, Al-Hadidi S, Cooper D, Lentzsch S, van Rhee F, Shah MR, Bag A, D'Souza A, Schinke C, Chakraborty R, Shah N, Mohan M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39192546"},{"title01":"Spatial transcriptomics reveals profound subclonal heterogeneity and T-cell dysfunction in extramedullary myeloma","title02":"Spatial transcriptomics reveals profound subclonal heterogeneity and T-cell dysfunction in extramedullary myeloma","journal":"Blood","issue":"2024 Aug 20:blood.2024024590. doi: 10.1182\/blood.2024024590. Online ahead of print.","author":"John M, Helal M, Duell J, Mattavelli G, Stanojkovska E, Afrin N, Leipold AM, Steinhardt MJ, Zhou X, \u017dihala D, Anilkumar Sithara A, Mersi J, Waldschmidt JM, Riedhammer C, Kadel SK, Truger M, Werner RA, Haferlach C, Einsele H, Kretzschmar K, Jel\u00ednek T, Rosenwald A, Kort\u00fcm KM, Riedel A, Rasche L.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39172759"},{"title01":"Efficacy and safety of teclistamab in patients with relapsed\/refractory multiple myeloma after BCMA-targeting therapies","title02":"Efficacy and safety of teclistamab in patients with relapsed\/refractory multiple myeloma after BCMA-targeting therapies","journal":"Blood","issue":"2024 Aug 20:blood.2023023616. doi: 10.1182\/blood.2023023616. Online ahead of print.","author":"Touzeau C, Krishnan AY, Moreau P, Perrot A, Usmani SZ, Manier S, Cavo M, Martinez Chamorro C, Nooka AK, Martin TG, Karlin L, Leleu X, Bahlis NJ, Besemer B, Pei L, Stein S, Wang Lin SX, Trancucci D, Verona R, Girgis S, Miao X, Uhlar C, Chastain K, Garfall A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39172760"},{"title01":"Role and timing of chromosome deletions in multiple myeloma","title02":"Role and timing of chromosome deletions in multiple myeloma","journal":"Blood","issue":"2024 Aug 15;144(7):688-689.","author":"Minvielle S, Letouz\u00e9 E.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39145940"},{"title01":"Emapalumab therapy for hemophagocytic lymphohistiocytosis prior to reduced-intensity transplantation improves chimerism","title02":"Emapalumab therapy for hemophagocytic lymphohistiocytosis prior to reduced-intensity transplantation improves chimerism","journal":"Blood","issue":"2024 Aug 27:blood.2024025977. doi: 10.1182\/blood.2024025977. Online ahead of print.","author":"Verkamp B, Jodele S, Sabulski A, Marsh RA, Kieser P, Jordan MB.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39190435"},{"title01":"How I approach intersectionality in hematopoietic stem cell transplantation","title02":"How I approach intersectionality in hematopoietic stem cell transplantation","journal":"Blood","issue":"2024 Aug 16:blood.2023020778. doi: 10.1182\/blood.2023020778. Online ahead of print.","author":"Hamad N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39158069"},{"title01":"Chromosome 9p trisomy increases stem cells clonogenic potential and fosters T-cell exhaustion in JAK2-mutant myeloproliferative neoplasms","title02":"Chromosome 9p trisomy increases stem cells clonogenic potential and fosters T-cell exhaustion in JAK2-mutant myeloproliferative neoplasms","journal":"Leukemia","issue":"2024 Aug 23. doi: 10.1038\/s41375-024-02373-w. Online ahead of print.","author":"Carretta C, Parenti S, Bertesi M, Rontauroli S, Badii F, Tavernari L, Genovese E, Malerba M, Papa E, Sperduti S, Enzo E, Mirabile M, Pedrazzi F, Neroni A, Tombari C, Mora B, Maffioli M, Mondini M, Brociner M, Maccaferri M, Tenedini E, Martinelli S, Bartalucci N, Bianchi E, Casarini L, Potenza L, Luppi M, Tagliafico E, Guglielmelli P, Simoni M, Passamonti F, Norfo R, Vannucchi AM, Manfredini R; MYNERVA (Myeloid NEoplasms Research Venture AIRC).","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39179669"},{"title01":"Identification of leukemia stem cell subsets with distinct transcriptional, epigenetic and functional properties","title02":"Identification of leukemia stem cell subsets with distinct transcriptional, epigenetic and functional properties","journal":"Leukemia","issue":"2024 Aug 21. doi: 10.1038\/s41375-024-02358-9. Online ahead of print.","author":"Boutzen H, Murison A, Oriecuia A, Bansal S, Arlidge C, Wang JCY, Lupien M, Kaufmann KB, Dick JE.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39169113"},{"title01":"New insights into pregnancy after stem-cell transplantation","title02":"New insights into pregnancy after stem-cell transplantation","journal":"Lancet Haematol","issue":"2024 Sep;11(9):e629.","author":"The Lancet Haematology.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39181612"},{"title01":"Second allogeneic stem-cell transplantation or donor lymphocyte infusion in patients who relapse after transplantation?","title02":"Second allogeneic stem-cell transplantation or donor lymphocyte infusion in patients who relapse after transplantation?","journal":"Lancet Haematol","issue":"2024 Sep;11(9):e642-e643.","author":"Robin M, Scheid C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39181614"},{"title01":"Human Leukocyte Antigen Mismatching and Survival in Contemporary Hematopoietic Cell Transplantation for Hematologic Malignancies","title02":"Human Leukocyte Antigen Mismatching and Survival in Contemporary Hematopoietic Cell Transplantation for Hematologic Malignancies","journal":"J Clin Oncol","issue":"2024 Aug 21:JCO2400582. doi: 10.1200\/JCO.24.00582. Online ahead of print.","author":"Arrieta-Bola\u00f1os E, Bonneville EF, Crivello P, Robin M, Gedde-Dahl T, Salmenniemi U, Kr\u00f6ger N, Yakoub-Agha I, Crawley C, Choi G, Broers AEC, Forcade E, Carre M, Poir\u00e9 X, Huynh A, Lenhoff S, Ciceri F, Tholouli E, Schroeder T, Deconinck E, Carlson K, de Wreede LC, Hoogenboom JD, Malard F, Ruggeri A, Fleischhauer K; Cellular Therapy and Immunobiology Working Party of the EBMT.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39167735"},{"title01":"Long-term outcome after allogeneic stem cell transplantation for GATA2 deficiency: An analysis of 67 adults and children from France and Belgium","title02":"Long-term outcome after allogeneic stem cell transplantation for GATA2 deficiency: An analysis of 67 adults and children from France and Belgium","journal":"Br J Haematol","issue":"2024 Aug 19. doi: 10.1111\/bjh.19691. Online ahead of print.","author":"Sicre de Fontbrune F, Chevillon F, Fahd M, Desseaux K, Poir\u00e9 X, Forcade E, Sterin A, Neven B, Gandemer V, Thepot S, Garnier A, Lioure B, Marcais A, Nguyen-Quoc S, Tavitian S, Vincent L, Donadieu J, Resche Riggon M, Chevret S, Pasquet M, Peffault de Latour R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39159950"},{"title01":"Activation of the HMGB1-TLR4 pathway impacts the functionality of bone marrow mesenchymal stem cells and disrupts macrophage polarization in immune thrombocytopenia","title02":"Activation of the HMGB1-TLR4 pathway impacts the functionality of bone marrow mesenchymal stem cells and disrupts macrophage polarization in immune thrombocytopenia","journal":"Br J Haematol","issue":"2024 Aug 21. doi: 10.1111\/bjh.19709. Online ahead of print.","author":"Liang Z, Zhang G, Gan G, Naren D, Liu X, Liu H, Nie D, Ma L.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39169447"},{"title01":"GVHD: bile duct stem cells under attack","title02":"GVHD: bile duct stem cells under attack","journal":"Blood","issue":"2024 Aug 22;144(8):805-807.","author":"Apostolova P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39172441"},{"title01":"How I approach intersectionality in hematopoietic stem cell transplantation","title02":"How I approach intersectionality in hematopoietic stem cell transplantation","journal":"Blood","issue":"2024 Aug 16:blood.2023020778. doi: 10.1182\/blood.2023020778. Online ahead of print.","author":"Hamad N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39158069"},{"title01":"Case 26-2024: A 59-Year-Old Woman with Aphasia, Anemia, and a Breast Mass","title02":"Case 26-2024: A 59-Year-Old Woman with Aphasia, Anemia, and a Breast Mass","journal":"N Engl J Med","issue":"2024 Aug 22;391(8):747-757.","author":"Wander SA, Thai JN, Wirth LJ, Soto DE, Kwait RM, Alzumaili BA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39167811"},{"title01":"HLA-lacking clones in aplastic anaemia: Adaptive or maladaptive?","title02":"HLA-lacking clones in aplastic anaemia: Adaptive or maladaptive?","journal":"Br J Haematol","issue":"2024 Aug 26. doi: 10.1111\/bjh.19731. Online ahead of print.","author":"Gurnari C, Lima ACM, Pagliuca S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39187391"},{"title01":"Haematopoietic regeneration by HLA-A*0206-deficient clones in severe aplastic anaemia without definitive immunosuppressive treatment","title02":"Haematopoietic regeneration by HLA-A*0206-deficient clones in severe aplastic anaemia without definitive immunosuppressive treatment","journal":"Br J Haematol","issue":"2024 Aug 18. doi: 10.1111\/bjh.19712. Online ahead of print.","author":"Zaimoku Y, Sakai K, Tsuji N, Hosomichi K, Yamada S, Tran DC, Kobayashi M, Sugiyama A, Hirayasu K, Mizumaki H, Ishiyama K, Hanayama R, Tomiyama Y, Nakao S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39155468"},{"title01":"Immune-mediated thrombotic thrombocytopenic purpura with ischaemic cerebral infarction preceding onset of thrombocytopenia and microangiopathic haemolytic anaemia: A case report","title02":"Immune-mediated thrombotic thrombocytopenic purpura with ischaemic cerebral infarction preceding onset of thrombocytopenia and microangiopathic haemolytic anaemia: A case report","journal":"Br J Haematol","issue":"2024 Aug 19. doi: 10.1111\/bjh.19717. Online ahead of print.","author":"Uchihara M, Sakai K, Shibata K, Saito K, Lammle B, Matsumoto M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39160065"},{"title01":"Menin Inhibition With Revumenib for KMT2A-Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101)","title02":"Menin Inhibition With Revumenib for KMT2A<\/i>-Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101)","journal":"J Clin Oncol","issue":"2024 Aug 9:JCO2400826. doi: 10.1200\/JCO.24.00826. Online ahead of print.","author":"Issa GC, Aldoss I, Thirman MJ, DiPersio J, Arellano M, Blachly JS, Mannis GN, Perl A, Dickens DS, McMahon CM, Traer E, Zwaan CM, Grove CS, Stone R, Shami PJ, Mantzaris I, Greenwood M, Shukla N, Cuglievan B, Kovacsovics T, Gu Y, Bagley RG, Madigan K, Chudnovsky Y, Nguyen HV, McNeer N, Stein EM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39121437"},{"title01":"How Could We Further Improve the Gilteritinib Maintenance After Allogeneic Hematopoietic Cell Transplantation in FLT3-Mutated AML?","title02":"How Could We Further Improve the Gilteritinib Maintenance After Allogeneic Hematopoietic Cell Transplantation in FLT3<\/i>-Mutated AML?","journal":"J Clin Oncol","issue":"2024 Jul 31:JCO2400566. doi: 10.1200\/JCO.24.00566. Online ahead of print.","author":"Fuji S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39083709"},{"title01":"An important oversight in WHO diagnostic classification: chronic myeloid leukemia with PML::RARA fusion clone","title02":"An important oversight in WHO diagnostic classification: chronic myeloid leukemia with PML::RARA<\/i> fusion clone","journal":"Haematologica","issue":"2024 Aug 8. doi: 10.3324\/haematol.2024.285562. Online ahead of print.","author":"Wang J, Wang S, Xiao Z, Chen Z, Qi L, Song B, Wang J, Li F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39113650"},{"title01":"Superior survival with allogeneic hematopoietic stem cell transplantation versus chemotherapy for high-risk adult acute lymphoblastic leukemia in a PDT-ALL-2016 pediatric-inspired cohort","title02":"Superior survival with allogeneic hematopoietic stem cell transplantation versus<\/i> chemotherapy for high-risk adult acute lymphoblastic leukemia in a PDT-ALL-2016 pediatric-inspired cohort","journal":"Haematologica","issue":"2024 Aug 1. doi: 10.3324\/haematol.2024.285590. Online ahead of print.","author":"Chen J, Cai Z, Huang Z, Lin J, Wang Z, Ou J, Xu X, Tang B, Ding C, Li J, Lin R, Zhang T, Xuan L, Liu Q, Zhou H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39086299"},{"title01":"Prenatal origin of NUTM1 gene rearrangement in infant B-cell precursor acute lymphoblastic leukaemia","title02":"Prenatal origin of NUTM1<\/i> gene rearrangement in infant B-cell precursor acute lymphoblastic leukaemia","journal":"Br J Haematol","issue":"2024 Aug 5. doi: 10.1111\/bjh.19685. Online ahead of print.","author":"Bardini M, Fazio G, Abascal LC, Meyer C, Maglia O, Sala S, Palamini S, Rebellato S, Marschalek R, Rizzari C, Biondi A, Cazzaniga G.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39099338"},{"title01":"POU6F2, a novel fusion partner of NUP98 in acute myeloid leukaemia: A case report","title02":"POU6F2<\/i>, a novel fusion partner of NUP98<\/i> in acute myeloid leukaemia: A case report","journal":"Br J Haematol","issue":"2024 Jul 27. doi: 10.1111\/bjh.19678. Online ahead of print.","author":"Choi YJ, Lee S, Kim Y, Shin S, Lee KA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39073102"},{"title01":"A nu mouse model of diffuse large B-cell lymphoma in constitutional Atm loss","title02":"A nu<\/i> mouse model of diffuse large B-cell lymphoma in constitutional Atm<\/i> loss","journal":"Haematologica","issue":"2024 Aug 8. doi: 10.3324\/haematol.2024.285973. Online ahead of print.","author":"Hilton LK.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39113649"},{"title01":"Co-shared genomic alterations within tumors from patients with both myeloproliferative neoplasms and lymphoma","title02":"Co-shared genomic alterations within tumors from patients with both myeloproliferative neoplasms and lymphoma","journal":"Haematologica","issue":"2024 Jul 25. doi: 10.3324\/haematol.2023.283798. Online ahead of print.","author":"Holst JM, Pedersen MB, Enemark MB, Hansen MC, Noerhave PR, Plesner TL, Frederiksen H, Moeller MB, Hamilton-Dutoit SJ, Noergaard P, Mortensen BK, Ommen HB, Stentoft J, Tam W, Ludvigsen M, Chan WC, Birkbak NJ, Inghirami G, D'Amore F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39049601"},{"title01":"Combination chemotherapy for Hodgkin lymphoma","title02":"Combination chemotherapy for Hodgkin lymphoma","journal":"Haematologica","issue":"2024 Aug 1;109(8):2383-2384.","author":"Moskowitz AJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39087411"},{"title01":"Central nervous system prophylaxis in large B-cell lymphoma: A British Society for Haematology Good Practice Paper","title02":"Central nervous system prophylaxis in large B-cell lymphoma: A British Society for Haematology Good Practice Paper","journal":"Br J Haematol","issue":"2024 Aug 11. doi: 10.1111\/bjh.19686. Online ahead of print.","author":"Wilson MR, Cwynarski K, Eyre TA, Smith J, Chaganti S, Fox CP, McKay P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39128894"},{"title01":"Prognostic stratification in DLBCL patients with aberrant MYC gene","title02":"Prognostic stratification in DLBCL patients with aberrant MYC<\/i> gene","journal":"Br J Haematol","issue":"2024 Aug 13. doi: 10.1111\/bjh.19699. Online ahead of print.","author":"Li JR, Shaw VR, Parthasarathy A, Li Y, Amos CI, Cheng C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39137931"},{"title01":"Long-term efficacy and safety of dose-dense and dose-intense ABVD without consolidation radiotherapy in patients with advanced Hodgkin lymphoma: A 15-year follow-up of the ABVD(DD-DI) phase II study","title02":"Long-term efficacy and safety of dose-dense and dose-intense ABVD without consolidation radiotherapy in patients with advanced Hodgkin lymphoma: A 15-year follow-up of the ABVD(DD-DI) phase II study","journal":"Br J Haematol","issue":"2024 Aug 1. doi: 10.1111\/bjh.19646. Online ahead of print.","author":"Corazzelli G, Cuccaro A, Morelli E, Arcamone M, De Chiara A, Paccone A, Petrillo A, Ibello F, Aversa C, Esposito M, Volzone F, Saggese M, Capobianco G, Sarno S, Sirica L, Crisci S, De Filippi R, Pinto A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39091109"},{"title01":"Radiological follow-up of osteonecrosis lesions in children and adolescents with Hodgkin lymphoma","title02":"Radiological follow-up of osteonecrosis lesions in children and adolescents with Hodgkin lymphoma","journal":"Br J Haematol","issue":"2024 Aug 3. doi: 10.1111\/bjh.19687. Online ahead of print.","author":"Aarnivala H, Giertz M, Michelsen SW, Bj\u00f6rklund C, Englund A, Gr\u00f6nroos M, Hjalgrim LL, Huttunen P, Niinim\u00e4ki T, Penno E, Pokka T, P\u00f6yh\u00f6nen T, Raittinen P, Ranta S, Svahn JE, T\u00f6rnudd L, Harila A, Niinim\u00e4ki R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39096138"},{"title01":"Combination of rituximab and methotrexate followed by rituximab and cytarabine in elderly patients with primary central nervous system lymphoma","title02":"Combination of rituximab and methotrexate followed by rituximab and cytarabine in elderly patients with primary central nervous system lymphoma","journal":"Br J Haematol","issue":"2024 Aug 5. doi: 10.1111\/bjh.19659. Online ahead of print.","author":"Yi JH, Kim SJ, Yang DH, Do YR, Won JH, Baek D, Shin HJ, Kim DS, Kim HJ, Kang KW, Bae SH, Kwon JH, Kwon JH, Park BB, Kim WS.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39104032"},{"title01":"Single gene mutations and prognosis in limited-stage follicular lymphoma treated with radiation therapy","title02":"Single gene mutations and prognosis in limited-stage follicular lymphoma treated with radiation therapy","journal":"Br J Haematol","issue":"2024 Aug 7. doi: 10.1111\/bjh.19698. Online ahead of print.","author":"Hershenfeld SA, Tobin JWD, Shelton V, Calvente L, Lajkosz K, Liu T, Brodtkorb M, d'Amore FA, Ludvigsen M, Baetz T, LeBrun D, Johnson N, Crump M, Hong M, Kuruvilla J, Tremblay-LeMay R, MacManus M, Tsang R, Hodgson DC, Gandhi MK, Kridel R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39112220"},{"title01":"How Could We Further Improve the Gilteritinib Maintenance After Allogeneic Hematopoietic Cell Transplantation in FLT3-Mutated AML?","title02":"How Could We Further Improve the Gilteritinib Maintenance After Allogeneic Hematopoietic Cell Transplantation in FLT3<\/i>-Mutated AML?","journal":"J Clin Oncol","issue":"2024 Jul 31:JCO2400566. doi: 10.1200\/JCO.24.00566. Online ahead of print.","author":"Fuji S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39083709"},{"title01":"Superior survival with allogeneic hematopoietic stem cell transplantation versus chemotherapy for high-risk adult acute lymphoblastic leukemia in a PDT-ALL-2016 pediatric-inspired cohort","title02":"Superior survival with allogeneic hematopoietic stem cell transplantation versus<\/i> chemotherapy for high-risk adult acute lymphoblastic leukemia in a PDT-ALL-2016 pediatric-inspired cohort","journal":"Haematologica","issue":"2024 Aug 1. doi: 10.3324\/haematol.2024.285590. Online ahead of print.","author":"Chen J, Cai Z, Huang Z, Lin J, Wang Z, Ou J, Xu X, Tang B, Ding C, Li J, Lin R, Zhang T, Xuan L, Liu Q, Zhou H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39086299"},{"title01":"How Could We Further Improve the Gilteritinib Maintenance After Allogeneic Hematopoietic Cell Transplantation in FLT3-Mutated AML?","title02":"How Could We Further Improve the Gilteritinib Maintenance After Allogeneic Hematopoietic Cell Transplantation in FLT3<\/i>-Mutated AML?","journal":"J Clin Oncol","issue":"2024 Jul 31:JCO2400566. doi: 10.1200\/JCO.24.00566. Online ahead of print.","author":"Fuji S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39083709"},{"title01":"Superior survival with allogeneic hematopoietic stem cell transplantation versus chemotherapy for high-risk adult acute lymphoblastic leukemia in a PDT-ALL-2016 pediatric-inspired cohort","title02":"Superior survival with allogeneic hematopoietic stem cell transplantation versus<\/i> chemotherapy for high-risk adult acute lymphoblastic leukemia in a PDT-ALL-2016 pediatric-inspired cohort","journal":"Haematologica","issue":"2024 Aug 1. doi: 10.3324\/haematol.2024.285590. Online ahead of print.","author":"Chen J, Cai Z, Huang Z, Lin J, Wang Z, Ou J, Xu X, Tang B, Ding C, Li J, Lin R, Zhang T, Xuan L, Liu Q, Zhou H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39086299"},{"title01":"Prognostic mutations identified by whole-exome sequencing and validation of the Molecular International Prognostic Scoring System in myelodysplastic syndromes after allogeneic haematopoietic stem cell transplantation","title02":"Prognostic mutations identified by whole-exome sequencing and validation of the Molecular International Prognostic Scoring System in myelodysplastic syndromes after allogeneic haematopoietic stem cell transplantation","journal":"Br J Haematol","issue":"2024 Aug 13. doi: 10.1111\/bjh.19707. Online ahead of print.","author":"Wang H, Li X, Qi J, Liu H, Chu T, Xu X, Qiu H, Fu C, Tang X, Ruan C, Wu D, Han Y.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39138006"},{"title01":"Clinical features and prognostic model for viral encephalitis after allogeneic haematopoietic stem cell transplantation","title02":"Clinical features and prognostic model for viral encephalitis after allogeneic haematopoietic stem cell transplantation","journal":"Br J Haematol","issue":"2024 Aug 4. doi: 10.1111\/bjh.19683. Online ahead of print.","author":"Wu J, He YC, Huang QS, He Y, Zhao P, Chen Q, Zhu XL, Fu HX, Kong J, Wang FR, Zhang YY, Mo XD, Yan CH, Lv M, Wang Y, Xu LP, Liu KY, Huang XJ, Zhang XH.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39099079"},{"title01":"Reduced-intensity conditioning with fludarabine\/busulfan versus fludarabine\/low-dose melphalan in patients with non-Hodgkin lymphoma undergoing allogeneic haematopoietic stem cell transplantation","title02":"Reduced-intensity conditioning with fludarabine\/busulfan versus fludarabine\/low-dose melphalan in patients with non-Hodgkin lymphoma undergoing allogeneic haematopoietic stem cell transplantation","journal":"Br J Haematol","issue":"2024 Jul 24. doi: 10.1111\/bjh.19651. Online ahead of print.","author":"Kamijo K, Shimomura Y, Kim SW, Ohigashi H, Ishikawa J, Eto T, Hiramoto N, Mizuno I, Iida S, Ueda Y, Matsuoka KI, Yakushijin K, Mori Y, Onizuka M, Fukuda T, Atsuta Y, Kako S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39049594"},{"title01":"A better approach to mismatched HSCT than PTCY?","title02":"A better approach to mismatched HSCT than PTCY?","journal":"Blood","issue":"2024 Aug 1;144(5):474-476.","author":"Morales E, Pulsipher MA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39088235"},{"title01":"Directionality of HLA-DP permissive mismatches improves risk prediction in HCT for acute leukemia and MDS","title02":"Directionality of HLA-DP permissive mismatches improves risk prediction in HCT for acute leukemia and MDS","journal":"Blood","issue":"2024 Aug 5:blood.2024024351. doi: 10.1182\/blood.2024024351. Online ahead of print.","author":"Arrieta-Bola\u00f1os E, van der Burg LLJ, Gedde-Dahl T, Robin M, Salmenniemi U, Kr\u00f6ger N, Yakoub-Agha I, Huynh A, Crawley CR, Deconinick E, Bulabois CE, Forcade E, Tholouli E, van der Hem JGK, van Balen P, Hoogenboom JD, de Wreede LC, Malard F, Ruggeri A, Fleischhauer K.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39102621"},{"title01":"Hematopoietic stem cell aging by the niche","title02":"Hematopoietic stem cell aging by the niche","journal":"Blood","issue":"2024 Jul 25;144(4):347-348.","author":"MacLean AL, Rudolph KL.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39052267"},{"title01":"Telomere length and clonal chromosomal alterations in peripheral blood of patients with severe aplastic anaemia","title02":"Telomere length and clonal chromosomal alterations in peripheral blood of patients with severe aplastic anaemia","journal":"Br J Haematol","issue":"2024 Aug 5. doi: 10.1111\/bjh.19681. Online ahead of print.","author":"Strauss JD, Brown DW, Zhou W, Dagnall C, Yuan JM, Im A, Savage SA, Wang Y, Rafati M, Spellman SR, Gadalla SM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39103182"},{"title01":"Proposals for Revised International Working Group-European LeukemiaNet Criteria for Anemia Response in Myelofibrosis","title02":"Proposals for Revised International Working Group-European LeukemiaNet Criteria for Anemia Response in Myelofibrosis","journal":"Blood","issue":"2024 Aug 8:blood.2024025802. doi: 10.1182\/blood.2024025802. Online ahead of print.","author":"Tefferi A, Barosi G, Passamonti F, Hernandez-Boluda JC, Bose P, D\u00f6hner K, Ellis M, Gangat N, Garcia JS, Gisslinger H, Gotlib J, Guglielmelli P, Gupta V, Harrison CN, Hexner EO, Hobbs GS, Kiladjian JJ, Koschmieder S, Kr\u00f6ger N, Kuykendall AT, Loscocco GG, Mascarenhas JO, Masarova L, Mesa R, Mora B, Odenike O, Oh ST, Pardanani AD, Patel AA, Pemmaraju N, Rambaldi A, Rampal RK, Sirhan S, Szuber N, Talpaz M, Vachhani P, Vannucchi AM, Barbui T.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39116296"},{"title01":"Mitigation of Checkpoint Inhibitor-Induced Autoimmune Hemolytic Anemia through Modulation of Purinergic Signaling","title02":"Mitigation of Checkpoint Inhibitor-Induced Autoimmune Hemolytic Anemia through Modulation of Purinergic Signaling","journal":"Blood","issue":"2024 Jul 16:blood.2024024230. doi: 10.1182\/blood.2024024230. Online ahead of print.","author":"Dei Zotti F, Qiu A, D'Agati VD, Jagnarine S, Kyritsis E, Miller A, Tredicine M, Fliginger D, Stone EF, Panch SR, Hudson KE.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39102659"},{"title01":"Anti-CD19 CAR T Cells in Refractory Immune Thrombocytopenia of SLE","title02":"Anti-CD19 CAR T Cells in Refractory Immune Thrombocytopenia of SLE","journal":"N Engl J Med","issue":"2024 Jul 25;391(4):376-378.","author":"Li M, Zhang Y, Jiang N, Ning C, Wang Q, Xu D, Wang Z, Lv L, Zhou D, Zeng X.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39047248"},{"title01":"Efgartigimod for primary immune thrombocytopenia: the ADVANCE IV trial","title02":"Efgartigimod for primary immune thrombocytopenia: the ADVANCE IV trial","journal":"Lancet","issue":"2024 Aug 3;404(10451):433-434.","author":"Ma RW, Liu K, Xie J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39097392"},{"title01":"Efgartigimod for primary immune thrombocytopenia: the ADVANCE IV trial","title02":"Efgartigimod for primary immune thrombocytopenia: the ADVANCE IV trial","journal":"Lancet","issue":"2024 Aug 3;404(10451):433.","author":"Jacobs JW, Booth GS, Stephens LD, Tormey CA, Adkins BD.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39097393"},{"title01":"Efgartigimod for primary immune thrombocytopenia: the ADVANCE IV trial – Authors’ reply","title02":"Efgartigimod for primary immune thrombocytopenia: the ADVANCE IV trial – Authors’ reply","journal":"Lancet","issue":"2024 Aug 3;404(10451):434.","author":"Al-Samkari H, B Bussel J, Miyakawa Y, Broome CM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39097394"},{"title01":"Platelet response to romiplostim amongst patients with newly diagnosed, persistent, and chronic immune thrombocytopenia in routine clinical practice in Denmark, Sweden, and Norway","title02":"Platelet response to romiplostim amongst patients with newly diagnosed, persistent, and chronic immune thrombocytopenia in routine clinical practice in Denmark, Sweden, and Norway","journal":"Br J Haematol","issue":"2024 Aug 5. doi: 10.1111\/bjh.19688. Online ahead of print.","author":"Christiansen CF, Risbo N, Ghanima W, Linder M, Bahmanyar S, Seesaghur A, Clouser M, N\u00f8rgaard M, S\u00f8rensen HT.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39102877"},{"title01":"Could machine learning revolutionize how we treat immune thrombocytopenia?","title02":"Could machine learning revolutionize how we treat immune thrombocytopenia?","journal":"Br J Haematol","issue":"2024 Aug 5. doi: 10.1111\/bjh.19684. Online ahead of print.","author":"Ghanima W, Cooper N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39103301"},{"title01":"Quality of life in childhood immune thrombocytopenia: Revision of the Kids’ ITP Tools (KIT)","title02":"Quality of life in childhood immune thrombocytopenia: Revision of the Kids’ ITP Tools (KIT)","journal":"Br J Haematol","issue":"2024 Jul 27. doi: 10.1111\/bjh.19662. Online ahead of print.","author":"Dhir V, Zhang C, Sucha E, Barrowman N, Grace RF, Grainger JD, Young NL, Klaassen RJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39072718"},{"title01":"Long-term complete remissions of refractory severe idiopathic immune thrombocytopenia treated with daratumumab: A\u00a0case\u00a0series","title02":"Long-term complete remissions of refractory severe idiopathic immune thrombocytopenia treated with daratumumab: A\u00a0case\u00a0series","journal":"Br J Haematol","issue":"2024 Jul 28. doi: 10.1111\/bjh.19660. Online ahead of print.","author":"Str\u00fc\u00dfmann T, Heinz J, W\u00e4sch R, Jung J, Engelhardt M, Duyster J, Finke J, Duque-Afonso J, Marks R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39073116"},{"title01":"Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults","title02":"Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults","journal":"N Engl J Med","issue":"2024 Jul 25;391(4):320-333.","author":"Litzow MR, Sun Z, Mattison RJ, Paietta EM, Roberts KG, Zhang Y, Racevskis J, Lazarus HM, Rowe JM, Arber DA, Wieduwilt MJ, Liedtke M, Bergeron J, Wood BL, Zhao Y, Wu G, Chang TC, Zhang W, Pratz KW, Dinner SN, Frey N, Gore SD, Bhatnagar B, Atallah EL, Uy GL, Jeyakumar D, Lin TL, Willman CL, DeAngelo DJ, Patel SB, Elliott MA, Advani AS, Tzachanis D, Vachhani P, Bhave RR, Sharon E, Little RF, Erba HP, Stone RM, Luger SM, Mullighan CG, Tallman MS.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39047240"},{"title01":"The VLA-4 integrin is constitutively active in circulating chronic lymphocytic leukemia cells via BCR autonomous signaling: a novel anchor-independent mechanism exploiting soluble blood-borne ligands","title02":"The VLA-4 integrin is constitutively active in circulating chronic lymphocytic leukemia cells via BCR autonomous signaling: a novel anchor-independent mechanism exploiting soluble blood-borne ligands","journal":"Leukemia","issue":"2024 Aug 14. doi: 10.1038\/s41375-024-02376-7. Online ahead of print.","author":"Tissino E, Gaglio A, Nicol\u00f2 A, Pozzo F, Bittolo T, Rossi FM, Bomben R, Nanni P, Cattarossi I, Zaina E, Zimbo AM, Ianna G, Capasso G, Forestieri G, Moia R, Datta M, H\u00e4rzschel A, Olivieri J, D'Arena G, Laurenti L, Zaja F, Chiarenza A, Palumbo GA, Martino EA, Gentile M, Rossi D, Gaidano G, Del Poeta G, Laureana R, Del Principe MI, Maity PC, Jumaa H, Hartmann TN, Zucchetto A, Gattei V.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39143370"},{"title01":"Rational combinatorial targeting by adapter CAR-T-cells (AdCAR-T) prevents antigen escape in acute myeloid leukemia","title02":"Rational combinatorial targeting by adapter CAR-T-cells (AdCAR-T) prevents antigen escape in acute myeloid leukemia","journal":"Leukemia","issue":"2024 Aug 3. doi: 10.1038\/s41375-024-02351-2. Online ahead of print.","author":"Atar D, Ruoff L, Mast AS, Krost S, Moustafa-Oglou M, Scheuermann S, Kristmann B, Feige M, Canak A, Wolsing K, Schlager L, Schilbach K, Zekri L, Ebinger M, Nixdorf D, Subklewe M, Schulte J, Lengerke C, Jeremias I, Werchau N, Mittelstaet J, Lang P, Handgretinger R, Schlegel P, Seitz CM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39095503"},{"title01":"BCR::ABL1 Proteolysis-targeting chimeras (PROTACs): The new frontier in the treatment of Ph(+) leukemias?","title02":"BCR::ABL1 Proteolysis-targeting chimeras (PROTACs): The new frontier in the treatment of Ph(+) leukemias?","journal":"Leukemia","issue":"2024 Aug 4. doi: 10.1038\/s41375-024-02365-w. Online ahead of print.","author":"Cruz-Rodriguez N, Tang H, Bateman B, Tang W, Deininger M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39098922"},{"title01":"Mutation in Bruton Tyrosine Kinase (BTK) A428D confers resistance To BTK-degrader therapy in chronic lymphocytic leukemia","title02":"Mutation in Bruton Tyrosine Kinase (BTK) A428D confers resistance To BTK-degrader therapy in chronic lymphocytic leukemia","journal":"Leukemia","issue":"2024 Aug;38(8):1818-1821. doi: 10.1038\/s41375-024-02317-4. Epub 2024 Jul 24.","author":"Wong RL, Choi MY, Wang HY, Kipps TJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39048721"},{"title01":"Older MRD vs. younger MUD in patients older than 50 years with AML in remission using post-transplant cyclophosphamide","title02":"Older MRD vs. younger MUD in patients older than 50 years with AML in remission using post-transplant cyclophosphamide","journal":"Leukemia","issue":"2024 Jul 24. doi: 10.1038\/s41375-024-02359-8. Online ahead of print.","author":"Piemontese S, Labopin M, Choi G, Broers AEC, Peccatori J, Meijer E, Van Gorkom G, Rovira M, Pascual Cascon MJ, Sica S, Vydra J, Kulagin A, Spyridonidis A, Nagler A, Bazarbachi A, Savani B, Brissot E, Sanz J, Mohty M, Ciceri F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39048722"},{"title01":"Chronic lymphocytic leukaemia","title02":"Chronic lymphocytic leukaemia","journal":"Lancet","issue":"2024 Jul 25:S0140-6736(24)00595-6. doi: 10.1016\/S0140-6736(24)00595-6. Online ahead of print.","author":"Jain N, Wierda WG, O'Brien S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39068951"},{"title01":"Genomic Determinants of Outcome in Acute Lymphoblastic Leukemia","title02":"Genomic Determinants of Outcome in Acute Lymphoblastic Leukemia","journal":"J Clin Oncol","issue":"2024 Aug 9:JCO2302238. doi: 10.1200\/JCO.23.02238. Online ahead of print.","author":"Chang TC, Chen W, Qu C, Cheng Z, Hedges D, Elsayed A, Pounds SB, Shago M, Rabin KR, Raetz EA, Devidas M, Cheng C, Angiolillo A, Baviskar P, Borowitz M, Burke MJ, Carroll A, Carroll WL, Chen IM, Harvey R, Heerema N, Iacobucci I, Wang JR, Jeha S, Larsen E, Mattano L, Maloney K, Pui CH, Ramirez NC, Salzer W, Willman C, Winick N, Wood B, Hunger SP, Wu G, Mullighan CG, Loh ML.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39121442"},{"title01":"Impact of Age on Pharmacogenomics and Treatment Outcomes of B-Cell Acute Lymphoblastic Leukemia","title02":"Impact of Age on Pharmacogenomics and Treatment Outcomes of B-Cell Acute Lymphoblastic Leukemia","journal":"J Clin Oncol","issue":"2024 Aug 5:JCO2400500. doi: 10.1200\/JCO.24.00500. Online ahead of print.","author":"Yoshimura S, Li Z, Gocho Y, Yang W, Crews KR, Lee SHR, Roberts KG, Mullighan CG, Relling MV, Yu J, Yeoh AEJ, Loh ML, Saygin C, Litzow MR, Jeha S, Karol SE, Inaba H, Pui CH, Konopleva M, Jain N, Stock W, Paietta E, Jabbour E, Kornblau SM, Evans WE, Yang JJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39102629"},{"title01":"Propofol, Anesthesia, and Neurocognitive Outcomes in Patients With Pediatric Leukemia: Are We Missing the Forest for the Trees?","title02":"Propofol, Anesthesia, and Neurocognitive Outcomes in Patients With Pediatric Leukemia: Are We Missing the Forest for the Trees?","journal":"J Clin Oncol","issue":"2024 Jul 24:JCO2400856. doi: 10.1200\/JCO.24.00856. Online ahead of print.","author":"Matava CT, Peyton J, von Ungern-Sternberg BS, Ing C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39047211"},{"title01":"Distinctive genomic features of human T-lymphotropic virus type 1-related adult T-cell leukemia-lymphoma in Western populations","title02":"Distinctive genomic features of human T-lymphotropic virus type 1-related adult T-cell leukemia-lymphoma in Western populations","journal":"Haematologica","issue":"2024 Aug 8. doi: 10.3324\/haematol.2024.285233. Online ahead of print.","author":"Myers CS, Williams E, Cornejo CB, Pongas G, Toomey NL, Sanches JA, Battistella M, Mo S, Pulitzer M, Moskaluk CA, Bhagat G, Ofori K, Davick JJ, Servitje O, Miyashiro D, Climent F, Ringbloom K, Duenas D, Law C, Zambrano SC, Malpica L, Beltran BE, Castro D, Barreto L, Brites C, Chapman JR, Choi J, Gru AA, Ramos JC.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39113648"},{"title01":"Repurposing CD19-directed immunotherapies for pediatric t(8;21) acute myeloid leukemia","title02":"Repurposing CD19-directed immunotherapies for pediatric t(8;21) acute myeloid leukemia","journal":"Haematologica","issue":"2024 Aug 8. doi: 10.3324\/haematol.2024.285707. Online ahead of print.","author":"Barneh F, Koedijk JB, Wijnen NE, Meulendijks T, Ashtiani M, Dunnebach E, Dautzenberg N, Cornel AM, Krippner-Heidenreich A, Klein K, Zwaan MC, Kuball J, Nierkens S, Cloos J, Kaspers GJL, Heidenreich O.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39113654"},{"title01":"LP-118 is a novel B-cell lymphoma 2 \/ extra-large inhibitor that demonstrates efficacy in models of venetoclax-resistant chronic lymphocytic leukemia","title02":"LP-118 is a novel B-cell lymphoma 2 \/ extra-large inhibitor that demonstrates efficacy in models of venetoclax-resistant chronic lymphocytic leukemia","journal":"Haematologica","issue":"2024 Aug 8. doi: 10.3324\/haematol.2023.284353. Online ahead of print.","author":"Ravikrishnan J, Diaz-Rohena DY, Muhowski E, Mo X, Lai TH, Misra S, Williams CD, Sanchez J, Mitchell A, Satpati S, Perry E, Kaufman T, Liu C, Lozanski A, Lozanski G, Rogers K, Kittai AS, Bhat SA, Collins MC, Davids MS, Jain N, Wierda WG, Lapalombella R, Byrd JC, Tan F, Chen Y, Chen Y, Shen Y, Anthony SP, Woyach JA, Sampath D.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39113656"},{"title01":"Contribution of copy number to improve risk stratification of adult T-cell acute lymphoblastic leukemia patients enrolled in measurable residual disease-oriented trials","title02":"Contribution of copy number to improve risk stratification of adult T-cell acute lymphoblastic leukemia patients enrolled in measurable residual disease-oriented trials","journal":"Haematologica","issue":"2024 Aug 8. doi: 10.3324\/haematol.2024.285416. Online ahead of print.","author":"Gonzalez-Gil C, Morgades M, Lopes T, Fuster-Tormo F, Montesinos P, Barba P, Diaz-Beya M, Hermosin L, Maluquer C, Gonzalez-Campos J, Bernal T, Arriaga MS, Zamora L, Pratcorona M, Martino R, Larrayoz MJ, Artola T, Torrent A, Vall-Llovera F, Tormo M, Gil C, Novo A, Martinez-Sanchez P, Ribera J, Queipo MP, Gonzalez-Martinez T, Cabrero M, Cladera A, Cervera J, Orfao A, Ribera JM, Genesca E.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39113657"},{"title01":"Hematopoietic cell transplantation for older acute myeloid leukemia patients in first complete remission: results of a randomized phase III study","title02":"Hematopoietic cell transplantation for older acute myeloid leukemia patients in first complete remission: results of a randomized phase III study","journal":"Haematologica","issue":"2024 Aug 8. doi: 10.3324\/haematol.2024.285879. Online ahead of print.","author":"Niederwieser D, Hasenclever D, Berdel WE, Biemond BJ, Al-Ali H, Chalandon Y, Van Gelder M, Junghan\u00df C, Gahrton G, H\u00e4nel M, Hehlmann R, Heinicke T, Hochhaus A, Iacobelli S, Kooy RVM, Kr\u00f6ger N, Janssen J, Jentzsch M, Breywisch F, Mohty M, Masouridi-Levrat S, Ossenkoppele G, Passweg J, P\u00f6nisch W, Schetelig J, Schliemann C, Schwind S, Stelljes M, Verdonck LF, Vucinic V, L\u00f6wenberg B, Cornelissen J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39113672"},{"title01":"Immunoglobulin prophylaxis prevents hospital admissions for fever in pediatric acute lymphoblastic leukemia: results of a multicenter randomized trial","title02":"Immunoglobulin prophylaxis prevents hospital admissions for fever in pediatric acute lymphoblastic leukemia: results of a multicenter randomized trial","journal":"Haematologica","issue":"2024 Aug 8. doi: 10.3324\/haematol.2024.285428. Online ahead of print.","author":"Thus KA, De Groot-Kruseman HA, Winkler-Seinstra P, Fiocco M, Segers H, Van den Bos C, Van der Sluis IM, Tissing WJE, Veening MA, Zwaan CM, Van Tilburg CM, Pieters R, Bierings M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39113674"},{"title01":"Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations","title02":"Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations","journal":"Blood","issue":"2024 Aug 12:blood.2024025409. doi: 10.1182\/blood.2024025409. Online ahead of print.","author":"D\u00f6hner H, DiNardo CD, Wei AH, L\u00f6wenberg B, Appelbaum F, Craddock C, Dombret H, Ebert BL, Fenaux P, Godley LA, Hasserjian RP, Larson RA, Levine RL, Miyazaki Y, Niederwieser D, Ossenkoppele GJ, R\u00f6llig C, Sierra J, Stein EM, Tallman MS, Tien HF, Wang J, Wierzbowska A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39133932"},{"title01":"A tumor suppressor of CLL: all (T-)bets are on","title02":"A tumor suppressor of CLL: all (T-)bets are on","journal":"Blood","issue":"2024 Aug 1;144(5):467-469.","author":"Moss P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39088232"},{"title01":"Asciminib Monotherapy as Frontline Treatment of Chronic-Phase Chronic Myeloid Leukemia: Results from the ASCEND Study","title02":"Asciminib Monotherapy as Frontline Treatment of Chronic-Phase Chronic Myeloid Leukemia: Results from the ASCEND Study","journal":"Blood","issue":"2024 Aug 5:blood.2024024657. doi: 10.1182\/blood.2024024657. Online ahead of print.","author":"Yeung DT, Shanmuganathan N, Reynolds J, Branford S, Walia M, Yong AS, Shortt J, Chee L, Viiala N, Cunningham I, Ross DM, D'Souza AB, Wright M, Harrup RA, Forsyth CJ, Filshie R, Lane SW, Browett PJ, Grove CS, Grigg AA, Hughes TP.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39102630"},{"title01":"Venetoclax-Obinutuzumab for previously untreated chronic lymphocytic leukemia: 6-year results of the phase 3 CLL14 study","title02":"Venetoclax-Obinutuzumab for previously untreated chronic lymphocytic leukemia: 6-year results of the phase 3 CLL14 study","journal":"Blood","issue":"2024 Jul 10:blood.2024024631. doi: 10.1182\/blood.2024024631. Online ahead of print.","author":"Al-Sawaf O, Robrecht S, Zhang C, Olivieri S, Chang YM, Fink AM, Tausch E, Schneider C, Ritgen M, Kreuzer KA, Sivcheva L, Niemann CU, Schwarer AP, Loscertales J, Weinkove R, Strumberg D, Kilfoyle A, Manzoor BS, Jawaid D, Emechebe N, Devine J, Boyer M, Runkel ED, Eichhorst B, Stilgenbauer S, Jiang Y, Hallek MJ, Fischer K.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39082668"},{"title01":"GNAS knockout potentiates HDAC3 inhibition through viral mimicry-related interferon responses in lymphoma","title02":"GNAS knockout potentiates HDAC3 inhibition through viral mimicry-related interferon responses in lymphoma","journal":"Leukemia","issue":"2024 Aug 8. doi: 10.1038\/s41375-024-02325-4. Online ahead of print.","author":"He MY, Tong KI, Liu T, Whittaker Hawkins R, Shelton V, Zeng Y, Bakhtiari M, Xiao Y, Zheng G, Sakhdari A, Yang L, Xu W, Brooks DG, Laister RC, He HH, Kridel R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39117798"},{"title01":"Tumor evolution analysis uncovered immune-escape related mutations in relapse of diffuse large B-cell lymphoma","title02":"Tumor evolution analysis uncovered immune-escape related mutations in relapse of diffuse large B-cell lymphoma","journal":"Leukemia","issue":"2024 Jul 30. doi: 10.1038\/s41375-024-02349-w. Online ahead of print.","author":"Han X, Sui J, Nie K, Zhao Y, Lv X, Xie J, Tan L, Au-Yeung RKH, Ma J, Inghirami G, Elemento O, Tam W, Liu Z.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39080353"},{"title01":"Brentuximab vedotin plus cyclophosphamide, doxorubicin, etoposide, and prednisone followed by brentuximab vedotin consolidation in CD30-positive peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 study","title02":"Brentuximab vedotin plus cyclophosphamide, doxorubicin, etoposide, and prednisone followed by brentuximab vedotin consolidation in CD30-positive peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 study","journal":"Lancet Haematol","issue":"2024 Jul 24:S2352-3026(24)00171-6. doi: 10.1016\/S2352-3026(24)00171-6. Online ahead of print.","author":"Herrera AF, Zain J, Savage KJ, Feldman T, Brammer JE, Chen L, Puverel S, Popplewell L, Budde LE, Mei M, Hosing C, Nair R, Leslie L, Daniels S, Peters L, Forman S, Rosen S, Kwak L, Iyer SP.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39067464"},{"title01":"Etoposide addition and brentuximab vedotin consolidation in first-line treatment of CD30-positive peripheral T-cell lymphoma: can we improve BV-CHP?","title02":"Etoposide addition and brentuximab vedotin consolidation in first-line treatment of CD30-positive peripheral T-cell lymphoma: can we improve BV-CHP?","journal":"Lancet Haematol","issue":"2024 Jul 24:S2352-3026(24)00207-2. doi: 10.1016\/S2352-3026(24)00207-2. Online ahead of print.","author":"Julia E, Bachy E.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39067466"},{"title01":"Enhancing the treatment landscape: PET-guided BrECADD for advanced-stage, classical Hodgkin lymphoma","title02":"Enhancing the treatment landscape: PET-guided BrECADD for advanced-stage, classical Hodgkin lymphoma","journal":"Lancet","issue":"2024 Jul 27;404(10450):312-313.","author":"Evens AM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39067891"},{"title01":"Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium","title02":"Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium","journal":"J Clin Oncol","issue":"2024 Aug 2:JCO2302786. doi: 10.1200\/JCO.23.02786. Online ahead of print.","author":"Jain MD, Spiegel JY, Nastoupil LJ, Tamaresis J, Ghobadi A, Lin Y, Lekakis L, Reagan P, Oluwole O, McGuirk J, Deol A, Dorritie KA, Sehgal AR, Goy A, Hill BT, Andreadis C, Munoz J, Ulrickson M, Westin J, Chavez JC, Patel D, Jacobs MT, Bansal R, Bennani NN, Patel VG, Rapoport AP, Vose JM, Miklos DB, Neelapu SS, Locke FL, Lunning M, Dahiya S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39094076"},{"title01":"US Food and Drug Administration’s Directive to Deal With Delayed Confirmatory Trials: Lessons From Pralatrexate and Belinostat for T-Cell Lymphoma","title02":"US Food and Drug Administration’s Directive to Deal With Delayed Confirmatory Trials: Lessons From Pralatrexate and Belinostat for T-Cell Lymphoma","journal":"J Clin Oncol","issue":"2024 Jul 25:JCO2400100. doi: 10.1200\/JCO.24.00100. Online ahead of print.","author":"Cliff ERS, Russler-Germain DA, Daval CJR, Kesselheim AS.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39052948"},{"title01":"Longitudinal Health-Related Quality of Life Among Patients With High-Risk Pediatric Hodgkin Lymphoma Treated on the Children’s Oncology Group AHOD 1331 Study","title02":"Longitudinal Health-Related Quality of Life Among Patients With High-Risk Pediatric Hodgkin Lymphoma Treated on the Children’s Oncology Group AHOD 1331 Study","journal":"J Clin Oncol","issue":"2024 Jul 26:JCO2400038. doi: 10.1200\/JCO.24.00038. Online ahead of print.","author":"Williams AM, Rodday AM, Pei Q, Henderson TO, Keller FG, Punnett A, Kelly KM, Castellino SM, Parsons SK.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39058966"},{"title01":"Distinctive genomic features of human T-lymphotropic virus type 1-related adult T-cell leukemia-lymphoma in Western populations","title02":"Distinctive genomic features of human T-lymphotropic virus type 1-related adult T-cell leukemia-lymphoma in Western populations","journal":"Haematologica","issue":"2024 Aug 8. doi: 10.3324\/haematol.2024.285233. Online ahead of print.","author":"Myers CS, Williams E, Cornejo CB, Pongas G, Toomey NL, Sanches JA, Battistella M, Mo S, Pulitzer M, Moskaluk CA, Bhagat G, Ofori K, Davick JJ, Servitje O, Miyashiro D, Climent F, Ringbloom K, Duenas D, Law C, Zambrano SC, Malpica L, Beltran BE, Castro D, Barreto L, Brites C, Chapman JR, Choi J, Gru AA, Ramos JC.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39113648"},{"title01":"LP-118 is a novel B-cell lymphoma 2 \/ extra-large inhibitor that demonstrates efficacy in models of venetoclax-resistant chronic lymphocytic leukemia","title02":"LP-118 is a novel B-cell lymphoma 2 \/ extra-large inhibitor that demonstrates efficacy in models of venetoclax-resistant chronic lymphocytic leukemia","journal":"Haematologica","issue":"2024 Aug 8. doi: 10.3324\/haematol.2023.284353. Online ahead of print.","author":"Ravikrishnan J, Diaz-Rohena DY, Muhowski E, Mo X, Lai TH, Misra S, Williams CD, Sanchez J, Mitchell A, Satpati S, Perry E, Kaufman T, Liu C, Lozanski A, Lozanski G, Rogers K, Kittai AS, Bhat SA, Collins MC, Davids MS, Jain N, Wierda WG, Lapalombella R, Byrd JC, Tan F, Chen Y, Chen Y, Shen Y, Anthony SP, Woyach JA, Sampath D.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39113656"},{"title01":"Reduced-intensity conditioning with fludarabine\/busulfan versus fludarabine\/low-dose melphalan in patients with non-Hodgkin lymphoma undergoing allogeneic haematopoietic stem cell transplantation","title02":"Reduced-intensity conditioning with fludarabine\/busulfan versus fludarabine\/low-dose melphalan in patients with non-Hodgkin lymphoma undergoing allogeneic haematopoietic stem cell transplantation","journal":"Br J Haematol","issue":"2024 Jul 24. doi: 10.1111\/bjh.19651. Online ahead of print.","author":"Kamijo K, Shimomura Y, Kim SW, Ohigashi H, Ishikawa J, Eto T, Hiramoto N, Mizuno I, Iida S, Ueda Y, Matsuoka KI, Yakushijin K, Mori Y, Onizuka M, Fukuda T, Atsuta Y, Kako S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39049594"},{"title01":"Rolling the DICEP on lymphoma salvage treatments? Choose wisely","title02":"Rolling the DICEP on lymphoma salvage treatments? Choose wisely","journal":"Br J Haematol","issue":"2024 Jul 27. doi: 10.1111\/bjh.19655. Online ahead of print.","author":"Balzarotti M, Bagnoli F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39072700"},{"title01":"Targeting CD25+ lymphoma cells with the antibody-drug conjugate camidanlumab tesirine as a single agent or in combination with targeted agents","title02":"Targeting CD25+ lymphoma cells with the antibody-drug conjugate camidanlumab tesirine as a single agent or in combination with targeted agents","journal":"Br J Haematol","issue":"2024 Jul 30. doi: 10.1111\/bjh.19658. Online ahead of print.","author":"Spriano F, Tarantelli C, Cascione L, Gaudio E, Golino G, Scalise L, Cacciapuoti MT, Zucca E, Stathis A, Van Berkel PH, Inghirami G, Zammarchi F, Bertoni F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39080847"},{"title01":"HHV-8+ diffuse large B-cell lymphoma with EBV coinfection occurring posttransplant","title02":"HHV-8+ diffuse large B-cell lymphoma with EBV coinfection occurring posttransplant","journal":"Blood","issue":"2024 Aug 8;144(6):677.","author":"Wang T, Silva O.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39115826"},{"title01":"A case of Richter transformation to diffuse large B-cell lymphoma with aberrant T-cell marker expression","title02":"A case of Richter transformation to diffuse large B-cell lymphoma with aberrant T-cell marker expression","journal":"Blood","issue":"2024 Aug 1;144(5):586.","author":"Arafat S, Don M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39088229"},{"title01":"Epigenetic agents plus anti-PD-1 reshapes tumor microenvironment and restores antitumor efficacy in Hodgkin lymphoma","title02":"Epigenetic agents plus anti-PD-1 reshapes tumor microenvironment and restores antitumor efficacy in Hodgkin lymphoma","journal":"Blood","issue":"2024 Aug 2:blood.2024024487. doi: 10.1182\/blood.2024024487. Online ahead of print.","author":"Nie J, Wang C, Zheng L, Liu Y, Wang C, Chang Y, Hu Y, Guo B, Pan Y, Yang Q, Hu X, Han W.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39093981"},{"title01":"Treatment of Relapsed\/Refractory MCL","title02":"Treatment of Relapsed\/Refractory MCL","journal":"Blood","issue":"2024 Jul 26:blood.2023022353. doi: 10.1182\/blood.2023022353. Online ahead of print.","author":"Silkenstedt E, Dreyling M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39059015"},{"title01":"Myeloma Therapy for Monoclonal Gammopathy of Thrombotic Significance","title02":"Myeloma Therapy for Monoclonal Gammopathy of Thrombotic Significance","journal":"N Engl J Med","issue":"2024 Aug 8;391(6):570-571.","author":"Salmasi G, Murray DL, Padmanabhan A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39115069"},{"title01":"A Belantamab Mafodotin Revival in Multiple Myeloma Therapy","title02":"A Belantamab Mafodotin Revival in Multiple Myeloma Therapy","journal":"N Engl J Med","issue":"2024 Aug 1;391(5):461-462.","author":"Trudel S, Stewart AK.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39083777"},{"title01":"Clinical implications of residual normal plasma cells within bone marrow across various disease stages in multiple myeloma","title02":"Clinical implications of residual normal plasma cells within bone marrow across various disease stages in multiple myeloma","journal":"Leukemia","issue":"2024 Aug 2. doi: 10.1038\/s41375-024-02366-9. Online ahead of print.","author":"Yan W, Shi L, Xu J, Li L, Cui J, Liu Y, Zhou J, Du C, Yu T, Zhang S, Lv R, Sui W, Deng S, Li X, Du X, Xu Y, Zou D, Qiu L, Hao M, An G.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39095502"},{"title01":"Anti-BCMA\/GPRC5D bispecific CAR T cells for relapsed or refractory multiple myeloma: is 1\u2009+\u20091 greater than 2?","title02":"Anti-BCMA\/GPRC5D bispecific CAR T cells for relapsed or refractory multiple myeloma: is 1\u2009+\u20091 greater than 2?","journal":"Lancet Haematol","issue":"2024 Jul 23:S2352-3026(24)00205-9. doi: 10.1016\/S2352-3026(24)00205-9. Online ahead of print.","author":"Li C, Mei H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39059404"},{"title01":"Anti-BCMA\/GPRC5D bispecific CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, single-centre, phase 1 trial","title02":"Anti-BCMA\/GPRC5D bispecific CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, single-centre, phase 1 trial","journal":"Lancet Haematol","issue":"2024 Jul 23:S2352-3026(24)00176-5. doi: 10.1016\/S2352-3026(24)00176-5. Online ahead of print.","author":"Zhou D, Sun Q, Xia J, Gu W, Qian J, Zhuang W, Yan Z, Cheng H, Chen W, Zhu F, Qi K, Li D, Sang W, Zhu L, Ma S, Li H, Zhang H, Qiu T, Yan D, Zhang Y, Peng S, Chang AH, Xu K, Li Z.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39059405"},{"title01":"Isatuximab plus carfilzomib-dexamethasone versus carfilzomib-dexamethasone in patients with relapsed multiple myeloma (IKEMA): overall survival analysis of a phase 3, randomised, controlled trial","title02":"Isatuximab plus carfilzomib-dexamethasone versus carfilzomib-dexamethasone in patients with relapsed multiple myeloma (IKEMA): overall survival analysis of a phase 3, randomised, controlled trial","journal":"Lancet Haematol","issue":"2024 Jul 24:S2352-3026(24)00148-0. doi: 10.1016\/S2352-3026(24)00148-0. Online ahead of print.","author":"Yong K, Martin T, Dimopoulos MA, Mikhael J, Capra M, Facon T, Hajek R, \u0160pi\u010dka I, Baker R, Kim K, Martinez G, Min CK, Pour L, Leleu X, Oriol A, Koh Y, Suzuki K, Casca F, Mac\u00e9 S, Risse ML, Moreau P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39067465"},{"title01":"Isatuximab plus carfilzomib-dexamethasone for relapsed multiple myeloma","title02":"Isatuximab plus carfilzomib-dexamethasone for relapsed multiple myeloma","journal":"Lancet Haematol","issue":"2024 Jul 24:S2352-3026(24)00220-5. doi: 10.1016\/S2352-3026(24)00220-5. Online ahead of print.","author":"Maruyama D, Yamauchi N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39067467"},{"title01":"Unlocking the therapeutic potential of selective CDK7 and BRD4 Inhibition against multiple myeloma cell growth","title02":"Unlocking the therapeutic potential of selective CDK7 and BRD4 Inhibition against multiple myeloma cell growth","journal":"Haematologica","issue":"2024 Jul 25. doi: 10.3324\/haematol.2024.285491. Online ahead of print.","author":"Yao Y, Deng S, Ng JF, Yuan M, Chakraborty C, JoyWeiler V, Munshi N, Fulciniti M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39049606"},{"title01":"Risk-adapted treatment in multiple myeloma: Does more make it merrier?","title02":"Risk-adapted treatment in multiple myeloma: Does more make it merrier?","journal":"Br J Haematol","issue":"2024 Jul 27. doi: 10.1111\/bjh.19676. Online ahead of print.","author":"Zanwar S, Galarza Fortuna GM, Sborov DW.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39072706"},{"title01":"MRD accelerating myeloma drug development","title02":"MRD accelerating myeloma drug development","journal":"Blood","issue":"2024 Jul 25;144(4):345-347.","author":"Costa LJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39052265"},{"title01":"Older MRD vs. younger MUD in patients older than 50 years with AML in remission using post-transplant cyclophosphamide","title02":"Older MRD vs. younger MUD in patients older than 50 years with AML in remission using post-transplant cyclophosphamide","journal":"Leukemia","issue":"2024 Jul 24. doi: 10.1038\/s41375-024-02359-8. Online ahead of print.","author":"Piemontese S, Labopin M, Choi G, Broers AEC, Peccatori J, Meijer E, Van Gorkom G, Rovira M, Pascual Cascon MJ, Sica S, Vydra J, Kulagin A, Spyridonidis A, Nagler A, Bazarbachi A, Savani B, Brissot E, Sanz J, Mohty M, Ciceri F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39048722"},{"title01":"Hematopoietic cell transplantation for older acute myeloid leukemia patients in first complete remission: results of a randomized phase III study","title02":"Hematopoietic cell transplantation for older acute myeloid leukemia patients in first complete remission: results of a randomized phase III study","journal":"Haematologica","issue":"2024 Aug 8. doi: 10.3324\/haematol.2024.285879. Online ahead of print.","author":"Niederwieser D, Hasenclever D, Berdel WE, Biemond BJ, Al-Ali H, Chalandon Y, Van Gelder M, Junghan\u00df C, Gahrton G, H\u00e4nel M, Hehlmann R, Heinicke T, Hochhaus A, Iacobelli S, Kooy RVM, Kr\u00f6ger N, Janssen J, Jentzsch M, Breywisch F, Mohty M, Masouridi-Levrat S, Ossenkoppele G, Passweg J, P\u00f6nisch W, Schetelig J, Schliemann C, Schwind S, Stelljes M, Verdonck LF, Vucinic V, L\u00f6wenberg B, Cornelissen J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39113672"},{"title01":"Prognostic mutations identified by whole-exome sequencing and validation of the Molecular International Prognostic Scoring System in myelodysplastic syndromes after allogeneic haematopoietic stem cell transplantation","title02":"Prognostic mutations identified by whole-exome sequencing and validation of the Molecular International Prognostic Scoring System in myelodysplastic syndromes after allogeneic haematopoietic stem cell transplantation","journal":"Br J Haematol","issue":"2024 Aug 13. doi: 10.1111\/bjh.19707. Online ahead of print.","author":"Wang H, Li X, Qi J, Liu H, Chu T, Xu X, Qiu H, Fu C, Tang X, Ruan C, Wu D, Han Y.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39138006"},{"title01":"Clinical features and prognostic model for viral encephalitis after allogeneic haematopoietic stem cell transplantation","title02":"Clinical features and prognostic model for viral encephalitis after allogeneic haematopoietic stem cell transplantation","journal":"Br J Haematol","issue":"2024 Aug 4. doi: 10.1111\/bjh.19683. Online ahead of print.","author":"Wu J, He YC, Huang QS, He Y, Zhao P, Chen Q, Zhu XL, Fu HX, Kong J, Wang FR, Zhang YY, Mo XD, Yan CH, Lv M, Wang Y, Xu LP, Liu KY, Huang XJ, Zhang XH.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39099079"},{"title01":"Allogeneic blood or marrow transplantation using haploidentical grandchildren donors and post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis","title02":"Allogeneic blood or marrow transplantation using haploidentical grandchildren donors and post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis","journal":"Br J Haematol","issue":"2024 Aug 4. doi: 10.1111\/bjh.19673. Online ahead of print.","author":"Aljawai YM, Tsai HL, Varadhan R, Jones RJ, Imus PH.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39099174"},{"title01":"Reduced-intensity conditioning with fludarabine\/busulfan versus fludarabine\/low-dose melphalan in patients with non-Hodgkin lymphoma undergoing allogeneic haematopoietic stem cell transplantation","title02":"Reduced-intensity conditioning with fludarabine\/busulfan versus fludarabine\/low-dose melphalan in patients with non-Hodgkin lymphoma undergoing allogeneic haematopoietic stem cell transplantation","journal":"Br J Haematol","issue":"2024 Jul 24. doi: 10.1111\/bjh.19651. Online ahead of print.","author":"Kamijo K, Shimomura Y, Kim SW, Ohigashi H, Ishikawa J, Eto T, Hiramoto N, Mizuno I, Iida S, Ueda Y, Matsuoka KI, Yakushijin K, Mori Y, Onizuka M, Fukuda T, Atsuta Y, Kako S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39049594"},{"title01":"Transplantation in Adult Patients with Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis: Yes or No?","title02":"Transplantation in Adult Patients with Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis: Yes or No?","journal":"Blood","issue":"2024 Aug 2:blood.2023023287. doi: 10.1182\/blood.2023023287. Online ahead of print.","author":"Yao S, He L, Suolitiken D, Zou H, Zhu Y, Wang Y.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39093986"},{"title01":"Hematopoietic cell transplantation for older acute myeloid leukemia patients in first complete remission: results of a randomized phase III study","title02":"Hematopoietic cell transplantation for older acute myeloid leukemia patients in first complete remission: results of a randomized phase III study","journal":"Haematologica","issue":"2024 Aug 8. doi: 10.3324\/haematol.2024.285879. Online ahead of print.","author":"Niederwieser D, Hasenclever D, Berdel WE, Biemond BJ, Al-Ali H, Chalandon Y, Van Gelder M, Junghan\u00df C, Gahrton G, H\u00e4nel M, Hehlmann R, Heinicke T, Hochhaus A, Iacobelli S, Kooy RVM, Kr\u00f6ger N, Janssen J, Jentzsch M, Breywisch F, Mohty M, Masouridi-Levrat S, Ossenkoppele G, Passweg J, P\u00f6nisch W, Schetelig J, Schliemann C, Schwind S, Stelljes M, Verdonck LF, Vucinic V, L\u00f6wenberg B, Cornelissen J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39113672"},{"title01":"A phase II study of post-remission therapy with pembrolizumab in older patients with acute myeloid leukemia","title02":"A phase II study of post-remission therapy with pembrolizumab in older patients with acute myeloid leukemia","journal":"Haematologica","issue":"2024 Aug 8. doi: 10.3324\/haematol.2024.285313. Online ahead of print.","author":"Quann K, Lontos K, Sehgal A, Raptis A, Im A, Redner RL, Dorritie KA, Agha M, Hou JZ, Farah R, Rossetti J, Normolle DP, Whiteside TL, Hsu YS, Boyiadzis M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39113675"},{"title01":"Drive to survive: gene dependency in T-cell acute lymphoblastic leukemia","title02":"Drive to survive: gene dependency in T-cell acute lymphoblastic leukemia","journal":"Haematologica","issue":"2024 Jul 25. doi: 10.3324\/haematol.2024.285806. Online ahead of print.","author":"Andrieu GP, Asnafi V.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39049600"},{"title01":"A transgenic mouse model of Down syndrome acute lymphoblastic leukemia identifies targetable vulnerabilities","title02":"A transgenic mouse model of Down syndrome acute lymphoblastic leukemia identifies targetable vulnerabilities","journal":"Haematologica","issue":"2024 Jul 25. doi: 10.3324\/haematol.2023.284761. Online ahead of print.","author":"Junco JJ, Rochette M, Alozie M, Rashid R, Terrell M, Zorman B, Sumazin P, Rowland L, Dettorre G, Powell RT, Stephan CC, Davies PJ, Martinez-Moczygemba M, Yang JJ, Rabin KR.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39049603"},{"title01":"Revumenib for patients with acute leukemia: a new tool for differentiation therapy","title02":"Revumenib for patients with acute leukemia: a new tool for differentiation therapy","journal":"Haematologica","issue":"2024 Aug 1. doi: 10.3324\/haematol.2022.282621. Online ahead of print.","author":"Salman MY, Stein EM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39086307"},{"title01":"Ponatinib alone or with chemo-immunotherapy in heavily pre-treated Philadelphia-like acute lymphoblastic leukemia: a CAMPUS ALL real-life study","title02":"Ponatinib alone or with chemo-immunotherapy in heavily pre-treated Philadelphia-like acute lymphoblastic leukemia: a CAMPUS ALL real-life study","journal":"Haematologica","issue":"2024 Aug 1. doi: 10.3324\/haematol.2024.285258. Online ahead of print.","author":"Kaiser F, Lunghi M, Cardinali D, Bellomarino V, Beldinanzi M, Starza ID, Malfona F, Basilico CM, Defina M, Mastaglio S, Giglio F, Lazzarotto D, Salutari P, Piccini M, Cardinali V, Pierini A, Fracchiolla NS, Di Biase F, Annunziata M, Di Trani M, Foa R, Chiaretti S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39086308"},{"title01":"Genome-wide study identifies novel genes associated with bone toxicities in children with acute lymphoblastic leukaemia","title02":"Genome-wide study identifies novel genes associated with bone toxicities in children with acute lymphoblastic leukaemia","journal":"Br J Haematol","issue":"2024 Aug 14. doi: 10.1111\/bjh.19696. Online ahead of print.","author":"Zhu Q, Nambiar R, Schultz E, Gao X, Liang S, Flamand Y, Stevenson K, Cole PD, Gennarini L, Harris MH, Kahn JM, Ladas EJ, Athale UH, Hoa Tran T, Michon B, Welch JJG, Sallan SE, Silverman LB, Kelly KM, Yao S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39143423"},{"title01":"Targeting the redox vulnerability of acute myeloid leukaemia cells with a combination of auranofin and vitamin C","title02":"Targeting the redox vulnerability of acute myeloid leukaemia cells with a combination of auranofin and vitamin C","journal":"Br J Haematol","issue":"2024 Aug 1. doi: 10.1111\/bjh.19680. Online ahead of print.","author":"Hei Z, Yang S, Ouyang G, Hanna J, Lepoivre M, Huynh T, Aguinaga L, Cassinat B, Maslah N, Bourge M, Golinelli-Cohen MP, Guittet O, Valli\u00e8res C, Vernis L, Fenaux P, Huang ME.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39087522"},{"title01":"Real-world comparative effectiveness of venetoclax-obinutuzumab versus Bruton tyrosine kinase inhibitors for frontline chronic lymphocytic leukaemia","title02":"Real-world comparative effectiveness of venetoclax-obinutuzumab versus Bruton tyrosine kinase inhibitors for frontline chronic lymphocytic leukaemia","journal":"Br J Haematol","issue":"2024 Jul 24. doi: 10.1111\/bjh.19613. Online ahead of print.","author":"Ghosh N, Manzoor BS, Fakhri B, Emechebe N, Alhasani H, Skarbnik A, Jawaid D, Shadman M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39049159"},{"title01":"Clinical outcomes of hypomethylating agents and venetoclax in newly diagnosed unfit and relapsed\/refractory paediatric, adolescent and young adult acute myeloid leukaemia patients","title02":"Clinical outcomes of hypomethylating agents and venetoclax in newly diagnosed unfit and relapsed\/refractory paediatric, adolescent and young adult acute myeloid leukaemia patients","journal":"Br J Haematol","issue":"2024 Jul 31. doi: 10.1111\/bjh.19679. Online ahead of print.","author":"LeBlanc FR, Breese EH, Burns KC, Chang EK, Jones LM, Lee L, Mizukawa B, Norris RE, O'Brien MM, Phillips CL, Perentesis JP, Rubinstein J, Pommert L.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39082439"},{"title01":"Proposals for Revised International Working Group-European LeukemiaNet Criteria for Anemia Response in Myelofibrosis","title02":"Proposals for Revised International Working Group-European LeukemiaNet Criteria for Anemia Response in Myelofibrosis","journal":"Blood","issue":"2024 Aug 8:blood.2024025802. doi: 10.1182\/blood.2024025802. Online ahead of print.","author":"Tefferi A, Barosi G, Passamonti F, Hernandez-Boluda JC, Bose P, D\u00f6hner K, Ellis M, Gangat N, Garcia JS, Gisslinger H, Gotlib J, Guglielmelli P, Gupta V, Harrison CN, Hexner EO, Hobbs GS, Kiladjian JJ, Koschmieder S, Kr\u00f6ger N, Kuykendall AT, Loscocco GG, Mascarenhas JO, Masarova L, Mesa R, Mora B, Odenike O, Oh ST, Pardanani AD, Patel AA, Pemmaraju N, Rambaldi A, Rampal RK, Sirhan S, Szuber N, Talpaz M, Vachhani P, Vannucchi AM, Barbui T.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39116296"},{"title01":"Genetic Risk Stratification and Outcomes Among Treatment-Naive Patients With AML Treated With Venetoclax and Azacitidine","title02":"Genetic Risk Stratification and Outcomes Among Treatment-Naive Patients With AML Treated With Venetoclax and Azacitidine","journal":"Blood","issue":"2024 Aug 12:blood.2024024944. doi: 10.1182\/blood.2024024944. Online ahead of print.","author":"D\u00f6hner H, Pratz KW, DiNardo CD, Wei AH, Jonas BA, Pullarkat V, Thirman MJ, R\u00e9cher C, Schuh AC, Babu S, Li X, Ku G, Liu Z, Sun Y, Potluri J, Dail M, Chyla B, Pollyea DA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39133921"},{"title01":"Directionality of HLA-DP permissive mismatches improves risk prediction in HCT for acute leukemia and MDS","title02":"Directionality of HLA-DP permissive mismatches improves risk prediction in HCT for acute leukemia and MDS","journal":"Blood","issue":"2024 Aug 5:blood.2024024351. doi: 10.1182\/blood.2024024351. Online ahead of print.","author":"Arrieta-Bola\u00f1os E, van der Burg LLJ, Gedde-Dahl T, Robin M, Salmenniemi U, Kr\u00f6ger N, Yakoub-Agha I, Huynh A, Crawley CR, Deconinick E, Bulabois CE, Forcade E, Tholouli E, van der Hem JGK, van Balen P, Hoogenboom JD, de Wreede LC, Malard F, Ruggeri A, Fleischhauer K.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39102621"}]